UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form	10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 000-04065

Lancaster Colony Corporation
(Exact name of registrant as specified in its charter)
Ohio		13-1955943
---	---	---
(State or other jurisdiction of<br><br>incorporation or organization)		(I.R.S. Employer<br><br>Identification No.)
380 Polaris Parkway	Suite 400
Westerville	Ohio	43082
(Address of principal executive offices)		(Zip Code)
(614)	224-7141
---	---
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	ý	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ý

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, without par value	LANC	NASDAQ Global Select Market

As of April 17, 2020, there were approximately

27,516,000

shares of Common Stock, without par value, outstanding.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

PART I – FINANCIAL INFORMATION		3
Item 1.	Condensed Consolidated Financial Statements (unaudited):
	Condensed Consolidated Balance Sheets – March 31, 2020 and June 30, 2019	3
	Condensed Consolidated Statements of Income – Three and Nine Months Ended March 31, 2020 and 2019	4
	Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended March 31, 2020 and 2019	5
	Condensed Consolidated Statements of Cash Flows – Nine Months Ended March 31, 2020 and 2019	6
	Condensed Consolidated Statements of Shareholders’ Equity – Nine Months Ended March 31, 2020 and 2019	7
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27
Item 4.	Controls and Procedures	27
PART II – OTHER INFORMATION		28
Item 1A.	Risk Factors	28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28
Item 5.	Other Information	29
Item 6.	Exhibits	29
SIGNATURES		30
INDEX TO EXHIBITS		31

PART I – FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(Amounts in thousands, except share data)	March 31, <br>2020			June 30, <br>2019
ASSETS
Current Assets:
Cash and equivalents	$	177,798		$	196,288
Receivables	87,649			75,691
Inventories:
Raw materials	40,108			30,647
Finished goods	56,151			55,425
Total inventories	96,259			86,072
Other current assets	20,269			10,518
Total current assets	381,975			368,569
Property, Plant and Equipment:
Land, buildings and improvements	181,671			163,094
Machinery and equipment	389,200			340,232
Total cost	570,871			503,326
Less accumulated depreciation	274,436			256,282
Property, plant and equipment-net	296,435			247,044
Other Assets:
Goodwill	208,371			208,371
Other intangible assets-net	66,460			70,277
Operating lease right-of-use assets	24,469			—
Other noncurrent assets	15,342			11,138
Total	$	993,052		$	905,399
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	90,818		$	76,670
Accrued liabilities	46,328			43,036
Total current liabilities	137,146			119,706
Noncurrent Operating Lease Liabilities	19,292			—
Other Noncurrent Liabilities	31,306			35,938
Deferred Income Taxes	32,024			22,882
Commitments and Contingencies
Shareholders’ Equity:
Preferred stock-authorized 3,050,000 shares; outstanding-none
Common stock-authorized 75,000,000 shares; outstanding-March-27,515,651 shares; June-27,491,497 shares	124,221			122,844
Retained earnings	1,409,994			1,359,782
Accumulated other comprehensive loss	(10,099		)	(10,308		)
Common stock in treasury, at cost	(750,832		)	(745,445		)
Total shareholders’ equity	773,284			726,873
Total	$	993,052		$	905,399

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

	Three Months Ended <br>March 31,				Nine Months Ended <br>March 31,
(Amounts in thousands, except per share data)	2020		2019		2020		2019
Net Sales	$	321,363	$	317,882	$	1,013,534	$	984,117
Cost of Sales	244,401		242,485		744,575		736,129
Gross Profit	76,962		75,397		268,959		247,988
Selling, General and Administrative Expenses	46,907		37,981		132,109		109,902
Change in Contingent Consideration	65		88		192		(9,517		)
Restructuring and Impairment Charges	—		—		886		—
Operating Income	29,990		37,328		135,772		147,603
Other, Net	727		1,329		3,031		3,682
Income Before Income Taxes	30,717		38,657		138,803		151,285
Taxes Based on Income	8,288		8,053		32,205		33,746
Net Income	$	22,429	$	30,604	$	106,598	$	117,539
Net Income Per Common Share:
Basic	$	0.82	$	1.11	$	3.88	$	4.28
Diluted	$	0.81	$	1.11	$	3.87	$	4.26
Weighted Average Common Shares Outstanding:
Basic	27,457		27,448		27,447		27,436
Diluted	27,501		27,549		27,502		27,543

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

	Three Months Ended <br>March 31,						Nine Months Ended <br>March 31,
(Amounts in thousands)	2020			2019			2020			2019
Net Income	$	22,429		$	30,604		$	106,598		$	117,539
Other Comprehensive Income:
Defined Benefit Pension and Postretirement Benefit Plans:
Amortization of loss, before tax	136			102			409			307
Amortization of prior service credit, before tax	(45		)	(46		)	(136		)	(137		)
Total Other Comprehensive Income, Before Tax	91			56			273			170
Tax Attributes of Items in Other Comprehensive Income:
Amortization of loss, tax	(31		)	(24		)	(95		)	(72		)
Amortization of prior service credit, tax	10			11			31			32
Total Tax Expense	(21		)	(13		)	(64		)	(40		)
Other Comprehensive Income, Net of Tax	70			43			209			130
Comprehensive Income	$	22,499		$	30,647		$	106,807		$	117,669

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended <br>March 31,
(Amounts in thousands)	2020			2019
Cash Flows From Operating Activities:
Net income	$	106,598		$	117,539
Adjustments to reconcile net income to net cash provided by operating activities:
Impacts of noncash items:
Depreciation and amortization	27,672			22,677
Change in contingent consideration	192			(9,517		)
Deferred income taxes and other changes	9,625			3,910
Stock-based compensation expense	4,337			4,542
Restructuring and impairment charges	(268		)	—
Pension plan activity	(458		)	(602		)
Changes in operating assets and liabilities:
Receivables	(11,958		)	(6,220		)
Inventories	(10,187		)	(766		)
Other current assets	(15,590		)	3,080
Accounts payable and accrued liabilities	9,175			8,780
Net cash provided by operating activities	119,138			143,423
Cash Flows From Investing Activities:
Payments for property additions	(72,006		)	(43,966		)
Cash paid for acquisitions, net of cash acquired	—			(57,540		)
Other-net	(389		)	(592		)
Net cash used in investing activities	(72,395		)	(102,098		)
Cash Flows From Financing Activities:
Payment of dividends	(56,386		)	(52,244		)
Purchase of treasury stock	(5,387		)	(5,032		)
Tax withholdings for stock-based compensation	(2,960		)	(2,209		)
Other-net	(500		)	(203		)
Net cash used in financing activities	(65,233		)	(59,688		)
Net change in cash and equivalents	(18,490		)	(18,363		)
Cash and equivalents at beginning of year	196,288			205,752
Cash and equivalents at end of period	$	177,798		$	187,389
Supplemental Disclosure of Operating Cash Flows:
Net cash payments for income taxes	$	30,355		$	25,373

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(UNAUDITED)


(Amounts in thousands,except per share data)					Retained<br>Earnings			Accumulated<br>Other<br>Comprehensive<br>Loss			Treasury<br>Stock			Total<br>Shareholders’<br>Equity
		Amount
Balance, June 30, 2019		$	122,844		$	1,359,782		$	(10,308	)	$	(745,445	)	$	726,873
Net income					40,745									40,745
Net pension and postretirement benefit gains, net of 21 tax effect								70						70
Cash dividends - common stock (0.65 per share)					(17,869		)							(17,869		)
Purchase of treasury stock	)										(1,465		)	(1,465		)
Stock-based plans		(125		)										(125		)
Stock-based compensation expense		1,436												1,436
Balance, September 30, 2019		$	124,155		$	1,382,658		$	(10,238	)	$	(746,910	)	$	749,665
Net income					43,424									43,424
Net pension and postretirement benefit gains, net of 22 tax effect								69						69
Cash dividends - common stock (0.70 per share)					(19,245		)							(19,245		)
Purchase of treasury stock											(7		)	(7		)
Stock-based plans		(2,571		)										(2,571		)
Stock-based compensation expense		1,423												1,423
Balance, December 31, 2019		$	123,007		$	1,406,837		$	(10,169	)	$	(746,917	)	$	772,758
Net income					22,429									22,429
Net pension and postretirement benefit gains, net of 21 tax effect								70						70
Cash dividends - common stock (0.70 per share)					(19,272		)							(19,272		)
Purchase of treasury stock	)										(3,915		)	(3,915		)
Stock-based plans		(264		)										(264		)
Stock-based compensation expense		1,478												1,478
Balance, March 31, 2020		$	124,221		$	1,409,994		$	(10,099	)	$	(750,832	)	$	773,284

All values are in US Dollars.

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (continued)

(UNAUDITED)


(Amounts in thousands,except per share data)					Retained<br>Earnings			Accumulated<br>Other<br>Comprehensive<br>Loss			Treasury<br>Stock			Total<br>Shareholders’<br>Equity
		Amount
Balance, June 30, 2018		$	119,232		$	1,279,343		$	(8,259	)	$	(738,034	)	$	652,282
Net income					39,028									39,028
Net pension and postretirement benefit gains, net of 13 tax effect								44						44
Cash dividends - common stock (0.60 per share)					(16,495		)							(16,495		)
Purchase of treasury stock	)										(1,593		)	(1,593		)
Stock-based plans		(778		)										(778		)
Stock-based compensation expense		1,531												1,531
Balance, September 30, 2018		$	119,985		$	1,301,876		$	(8,215	)	$	(739,627	)	$	674,019
Net income					47,907									47,907
Net pension and postretirement benefit gains, net of 14 tax effect								43						43
Cash dividends - common stock (0.65 per share)					(17,875		)							(17,875		)
Purchase of treasury stock	)										(166		)	(166		)
Stock-based plans		(988		)										(988		)
Stock-based compensation expense		1,831												1,831
Balance, December 31, 2018		$	120,828		$	1,331,908		$	(8,172	)	$	(739,793	)	$	704,771
Net income					30,604									30,604
Net pension and postretirement benefit gains, net of 13 tax effect								43						43
Cash dividends - common stock (0.65 per share)					(17,874		)							(17,874		)
Purchase of treasury stock	)										(3,273		)	(3,273		)
Stock-based plans		(443		)										(443		)
Stock-based compensation expense		1,180												1,180
Balance, March 31, 2019		$	121,565		$	1,344,638		$	(8,129	)	$	(743,066	)	$	715,008

All values are in US Dollars.

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Note 1 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Lancaster Colony Corporation and our wholly-owned subsidiaries, collectively referred to as “we,” “us,” “our,” “registrant” or the “Company” and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in our 2019 Annual Report on Form 10-K. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2020 refers to fiscal 2020, which is the period from July 1, 2019 to June 30, 2020.

Deferred Software Costs

We capitalize certain costs related to hosting arrangements that are service contracts (cloud computing arrangements). For the nine months ended March 31, 2020, we capitalized $6.6 million of deferred software costs related to cloud computing arrangements, primarily for amounts related to our new enterprise resource planning system.

Property, Plant and Equipment

Property, plant and equipment are recorded at cost, except for those acquired as part of a business combination, which are recorded at fair value at the time of purchase. We use the straight-line method of computing depreciation for financial reporting purposes based on the estimated useful lives of the corresponding assets. Purchases of property, plant and equipment included in Accounts Payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	March 31,
	2020		2019
Construction in progress in Accounts Payable	$	8,532	$	3,131

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Basic and diluted net income per common share were calculated as follows:

	Three Months Ended <br>March 31,						Nine Months Ended <br>March 31,
	2020			2019			2020			2019
Net income	$	22,429		$	30,604		$	106,598		$	117,539
Net income available to participating securities	(48		)	(52		)	(216		)	(212		)
Net income available to common shareholders	$	22,381		$	30,552		$	106,382		$	117,327
Weighted average common shares outstanding – basic	27,457			27,448			27,447			27,436
Incremental share effect from:
Nonparticipating restricted stock	1			1			2			3
Stock-settled stock appreciation rights	43			100			53			104
Weighted average common shares outstanding – diluted	27,501			27,549			27,502			27,543
Net income per common share – basic	$	0.82		$	1.11		$	3.88		$	4.28
Net income per common share – diluted	$	0.81		$	1.11		$	3.87		$	4.26

Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended <br>March 31,						Nine Months Ended <br>March 31,
	2020			2019			2020			2019
Accumulated other comprehensive loss at beginning of period	$	(10,169	)	$	(8,172	)	$	(10,308	)	$	(8,259	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss	143			111			429			335
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain	(7		)	(9		)	(20		)	(28		)
Amortization of prior service credit	(45		)	(46		)	(136		)	(137		)
Total other comprehensive income, before tax	91			56			273			170
Total tax expense	(21		)	(13		)	(64		)	(40		)
Other comprehensive income, net of tax	70			43			209			130
Accumulated other comprehensive loss at end of period	$	(10,099	)	$	(8,129	)	$	(10,099	)	$	(8,129	)

Significant Accounting Policies

There were no changes to our Significant Accounting Policies from those disclosed in our 2019 Annual Report on Form 10-K. However, see expanded disclosure of lease accounting policies in Note 5 due to the adoption of new lease accounting guidance.

Recently Issued Accounting Standards

In August 2018, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance related to the disclosure requirements for fair value measurements. The guidance removes, modifies and adds disclosures related to fair value. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. This guidance will be effective for us in fiscal 2021, including interim periods. As the guidance only relates to disclosures, there will be no impact on our financial position or results of operations.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Recently Adopted Accounting Standards

In February 2016, the FASB issued new accounting guidance to require lessees to recognize a right-of-use asset and a lease liability for leases with terms of more than 12 months and issued subsequent clarifications of this new guidance. This guidance retains the two classifications of a lease as either an operating or finance lease (previously referred to as a capital lease). Both lease classifications require the lessee to record a right-of-use asset and a lease liability based upon the present value of the lease payments. Finance leases will reflect the financial arrangement by recognizing interest expense on the lease liability separately from the amortization expense of the right-of-use asset. Operating leases will recognize lease expense (with no separate recognition of interest expense) on a straight-line basis over the term of the lease. The guidance requires expanded qualitative and quantitative disclosures, including additional information about the amounts recorded in the consolidated financial statements. In July 2018, the FASB issued guidance that allows for an alternate transition method whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than restating comparative periods. We adopted the new guidance on July 1, 2019 using this alternate transition method, but we did not record a cumulative-effect adjustment from initially applying the standard. We elected the package of practical expedients that permits us not to reassess our prior conclusions about lease identification, lease classification and initial direct costs and made an accounting policy election to exclude short-term leases with an initial term of 12 months or less from our Consolidated Balance Sheets. We have completed the implementation of a lease accounting system to enable the preparation of financial information and have implemented relevant accounting policies and internal controls surrounding the lease accounting process. As a result of adoption, we recognized a lease liability and right-of-use asset of $33.5 million and $31.7 million, respectively. The right-of-use asset balance reflects the reclassification of deferred rent and prepaid rent against the initial asset. The adoption did not impact our results of operations or cash flows. See additional lease disclosures in Note 5.

Note 2 – Acquisitions

Omni Baking Company LLC

On November 16, 2018, we acquired substantially all of the assets of Omni Baking Company LLC (“Omni”). Omni has been a long-time supplier of products to our frozen garlic bread operations and is based in Vineland, New Jersey. The purchase price of $22.3 million, which includes the post-closing working capital adjustment, was funded with cash on hand. Omni’s results of operations are allocated between our Retail and Foodservice segments in a manner consistent with our current segment allocations. These results have been included in our condensed consolidated financial statements from the date of acquisition.

Bantam Bagels, LLC

On October 19, 2018, we acquired all the assets of Bantam Bagels, LLC (“Bantam”). Bantam, a producer and marketer of frozen mini stuffed bagels and other frozen bread products sold to both the retail and foodservice channels, is based in New York, New York. The base purchase price of $33.1 million, which includes the post-closing working capital adjustment, was funded with cash on hand. This purchase price excludes contingent consideration relating to an additional earn-out payment which is tied to performance-based conditions. In general, the terms of the acquisition specify that the sellers will receive an earn-out based upon a pre-determined multiple of the defined adjusted EBITDA of Bantam for the twelve months ending December 31, 2023. We are unable to provide a range for the amount of this earn-out because it is based on the future adjusted EBITDA of Bantam, and the earn-out does not contain a minimum or maximum value. See further discussion of the earn-out in Note 3. Bantam’s results of operations are allocated between our Retail and Foodservice segments in a manner consistent with our current segment allocations. These results have been included in our condensed consolidated financial statements from the date of acquisition.

Note 3 – Fair Value

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. GAAP sets forth a three-level fair value hierarchy, which prioritizes the inputs used in measuring fair value. The three levels are as follows:

Level 1 – defined as observable inputs, such as quoted market prices in active markets.

Level 2 – defined as inputs other than quoted prices in active markets that are either directly or indirectly observable.

Level 3 – defined as unobservable inputs in which little or no market data exists, therefore, requiring an entity to develop its own assumptions.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Our financial assets and liabilities subject to the three-level fair value hierarchy consist principally of cash and equivalents, accounts receivable, accounts payable, contingent consideration payable and defined benefit pension plan assets. The estimated fair value of cash and equivalents, accounts receivable and accounts payable approximates their carrying value.

Our contingent consideration, which resulted from the earn-outs associated with our acquisitions of Bantam and Angelic Bakehouse, Inc. (“Angelic”), is measured at fair value on a recurring basis and is included in Other Noncurrent Liabilities on the Condensed Consolidated Balance Sheets. The following table summarizes our contingent consideration:

	Fair Value Measurements at March 31, 2020
	Level 1		Level 2		Level 3		Total
Contingent consideration - Bantam	$	—	$	—	$	9,092	$	9,092
Contingent consideration - Angelic	—		—		—		—
Total contingent consideration	$	—	$	—	$	9,092	$	9,092
	Fair Value Measurements at June 30, 2019
	Level 1		Level 2		Level 3		Total
Contingent consideration - Bantam	$	—	$	—	$	8,900	$	8,900
Contingent consideration - Angelic	—		—		—		—
Total contingent consideration	$	—	$	—	$	8,900	$	8,900

Bantam Contingent Consideration

This contingent consideration resulted from the earn-out associated with our October 19, 2018 acquisition of Bantam. In general, the terms of the acquisition specify the sellers will receive an earn-out based upon a pre-determined multiple of the defined adjusted EBITDA of Bantam for the twelve months ending December 31, 2023. The initial fair value of the contingent consideration was determined to be $8.0 million, which included a refinement to the purchase price allocation in the prior-year third quarter related to a change in assumptions. The fair value is measured on a recurring basis using a Monte Carlo simulation that randomly changes revenue growth, forecasted adjusted EBITDA and other uncertain variables to estimate an expected value. We record the present value of this amount by applying a discount rate. As this fair value measurement is based on significant inputs not observable in the market, it represents a Level 3 measurement within the fair value hierarchy.

The following table represents our Level 3 fair value measurements using significant other unobservable inputs for Bantam’s contingent consideration:

	Three Months Ended <br>March 31,					Nine Months Ended <br>March 31,
	2020		2019			2020		2019
Contingent consideration at beginning of period	$	9,027	$	8,995		$	8,900	$	—
Initial fair value - (reductions)/additions	—		(900		)	—		8,000
Change in contingent consideration included in operating income	65		88			192		183
Contingent consideration at end of period	$	9,092	$	8,183		$	9,092	$	8,183

Angelic Contingent Consideration

This contingent consideration resulted from the earn-out associated with our November 17, 2016 acquisition of Angelic. In general, the terms of the acquisition specify the sellers will receive an earn-out based upon a pre-determined multiple of the defined adjusted EBITDA of Angelic for fiscal 2021. The initial fair value of the contingent consideration was determined to be $13.9 million. The fair value is measured on a recurring basis using a present value approach, which incorporates factors such as revenue growth and forecasted adjusted EBITDA, to estimate an expected value. We record the present value of this amount by applying a discount rate. As this fair value measurement is based on significant inputs not observable in the market, it represents a Level 3 measurement within the fair value hierarchy. Our 2019 fair value measurements resulted in a $9.7 million reduction in the fair value of Angelic’s contingent consideration in the second quarter ended December 31, 2018 and a $7.4 million reduction in the fourth quarter ended June 30, 2019 based on changes in Angelic’s forecasted adjusted EBITDA for fiscal 2021. These adjustments were recorded in our Retail segment.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

The following table represents our Level 3 fair value measurements using significant other unobservable inputs for Angelic’s contingent consideration:

	Three Months Ended <br>March 31,				Nine Months Ended <br>March 31,
	2020		2019		2020		2019
Contingent consideration at beginning of period	$	—	$	7,380	$	—	$	17,080
Change in contingent consideration included in operating income	—		—		—		(9,700		)
Contingent consideration at end of period	$	—	$	7,380	$	—	$	7,380

Note 4 – Long-Term Debt

At June 30, 2019, we had an unsecured credit facility under which we could borrow, on a revolving credit basis, up to a maximum of $150 million at any one time, with potential to expand the total credit availability to $225 million subject to us obtaining consent of the issuing banks and certain other conditions.

On March 19, 2020, in the ordinary course of business, we entered into a new unsecured revolving credit facility (“New Credit Facility”), replacing the facility discussed above which was to expire in April 2021. The material terms and covenants of the New Credit Facility are substantially similar to our previous credit facility.

The New Credit Facility provides that we may borrow, on a revolving credit basis, up to a maximum of $150 million at any one time, with potential to expand the total credit availability to $225 million based on consent of the issuing banks and certain other conditions. The New Credit Facility expires on March 19, 2025, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternate base rate defined in the New Credit Facility. In the event that LIBOR becomes unavailable or is no longer deemed an appropriate reference rate, the New Credit Facility allows for the use of a benchmark replacement rate. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Due to the nature of its terms, when we have outstanding borrowings under the New Credit Facility, they will be classified as long-term debt.

At March 31, 2020 and June 30, 2019, we had no borrowings outstanding under these facilities. At March 31, 2020 and June 30, 2019, we had $2.8 million and $5.1 million, respectively, of standby letters of credit outstanding, which reduced the amount available for borrowing under these facilities. We paid no interest for the three and nine months ended March 31, 2020 and 2019.

The New Credit Facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions. There are two principal financial covenants: an interest expense test that requires us to maintain an interest coverage ratio not less than 2.5 to 1 at the end of each fiscal quarter; and an indebtedness test that requires us to maintain a consolidated leverage ratio not greater than 3.5 to 1, subject to certain exceptions. The interest coverage ratio is calculated by dividing Consolidated EBIT by Consolidated Interest Expense, and the leverage ratio is calculated by dividing Consolidated Net Debt by Consolidated EBITDA. All financial terms used in the covenant calculations are defined more specifically in the New Credit Facility.

Note 5 – Leases

General Lease Description

We have operating leases with initial noncancelable lease terms in excess of one year covering the rental of various facilities and equipment. Certain of these leases contain renewal options and some provide options to purchase during the lease term. Our operating leases include leases for real estate for some of our office and manufacturing facilities as well as manufacturing and non-manufacturing equipment used in our business. The remaining lease terms for these operating leases range from 1 year to 8 years.

We have finance leases with initial noncancelable lease terms in excess of one year covering the rental of various equipment. These leases are generally for manufacturing and non-manufacturing equipment used in our business. The remaining lease terms for these finance leases range from 3 years to 4 years.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Significant Assumptions and Judgments

Contract Contains a Lease

In evaluating our contracts to determine whether a contract is or contains a lease, we considered the following:

•	Whether explicitly or implicitly identified assets have been deployed in the contract; and
•	Whether we obtain substantially all of the economic benefits from the use of that underlying asset, and we can direct how and for what purpose the asset is used during the term of the contract.
---	---

Allocation of Consideration

In determining how to allocate consideration between lease and non-lease components in a contract that was deemed to contain a lease, we used judgment and consistent application of assumptions to reasonably allocate the consideration.

Options to Extend or Terminate Leases

We have leases which contain options to extend or terminate the leases. On a lease-by-lease basis, we have determined if the extension should be considered reasonably certain to be exercised and thus a right-of-use asset and a lease liability should be recorded.

Discount Rate

The discount rate for leases, if not explicitly stated in the lease, is the incremental borrowing rate, which is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.

We used a discount rate to calculate the present value of the lease liability at the date of adoption. In the development of the discount rate, we considered our internal borrowing rate, treasury security rates, collateral and credit risk specific to us, and our lease portfolio characteristics.

As of March 31, 2020, the weighted-average discount rate of our operating and finance leases was

3.0%

and

4.1%

, respectively.

Practical Expedients and Accounting Policy Elections

We elected the package of practical expedients that permits us not to reassess our prior conclusions about lease identification, lease classification and initial direct costs and made an accounting policy election to exclude short-term leases with an initial term of 12 months or less from our Consolidated Balance Sheets.

Amounts Recognized in the Financial Statements

The components of lease expense were as follows:

	Three Months Ended <br>March 31, 2020		Nine Months Ended <br>March 31, 2020
Operating lease cost in Cost of Sales and Selling, General and Administrative Expenses	$	2,379	$	6,520
Finance lease cost:
Amortization of assets in Cost of Sales	$	83	$	251
Interest on lease liabilities in Other, Net	18		57
Total finance lease cost	$	101	$	308
Short-term lease cost in Cost of Sales and Selling, General and Administrative Expenses	361		1,785
Total net lease cost	$	2,841	$	8,613

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Supplemental balance sheet information related to leases is as follows:

	March 31, 2020
Operating Leases
Operating Lease Right-Of-Use Assets	$	24,469
Current operating lease liabilities in Accrued Liabilities	$	6,903
Noncurrent Operating Lease Liabilities	19,292
Total operating lease liabilities	$	26,195
Finance Leases
Finance lease right-of-use assets in Property, Plant and Equipment-Net	$	1,799
Current finance lease liabilities in Accrued Liabilities	$	446
Noncurrent finance lease liabilities in Other Noncurrent Liabilities	1,183
Total finance lease liabilities	$	1,629

Supplemental cash flow information related to leases is as follows:

	Nine Months Ended <br>March 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	6,675
Operating cash flows from finance leases	$	57
Financing cash flows from finance leases	$	322
Supplemental noncash information on lease liabilities arising from obtaining right-of-use assets	$	4,867
Supplemental noncash information on lease liabilities removed due to purchase of leased asset	$	5,765

As of March 31, 2020, the maturities of lease liabilities were as follows:

	Operating Leases			Finance Leases
Three months ending June 30, 2020	$	2,220		$	126
2021	6,961			505
2022	5,917			505
2023	4,631			493
2024	3,768			121
Thereafter	4,694			—
Total minimum payments	$	28,191		$	1,750
Less amount representing interest	(1,996		)	(121		)
Present value of lease obligations	$	26,195		$	1,629

As of March 31, 2020, the weighted-average remaining term of our operating and finance leases was 4.8 years and 3.5 years, respectively.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

As previously disclosed in our 2019 Annual Report on Form 10-K and under the previous lease accounting standard (Topic 840), as of June 30, 2019, future minimum lease payments under noncancelable leases with initial lease terms in excess of one year were as follows:

	Operating Leases		Capital Leases
2020	$	8,261	$	505
2021	7,136		505
2022	6,345		505
2023	4,992		493
2024	4,619		121
Thereafter	6,901		—
Total minimum payments	$	38,254	$	2,129
Less amount representing interest			(178		)
Present value of capital lease obligations			$	1,951

Note 6 – Contingencies

At March 31, 2020, we were a party to various claims and litigation matters arising in the ordinary course of business. Such matters did not have a material effect on the current-year results of operations and, in our opinion, their ultimate disposition will not have a material effect on our consolidated financial statements.

A novel strain of coronavirus (“COVID-19”) was first identified in Wuhan, China in December 2019. On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. In the U.S., state and local governments recommended or mandated actions to slow the transmission of COVID-19. We continue to monitor the rapidly evolving situation and guidance from authorities, including federal, state and local public health departments. We reviewed the carrying value of our assets as of March 31, 2020 and recorded additional reserves for inventory and receivables related to the impact of COVID-19 on our Foodservice segment. The future impact of COVID-19 on our results of operations, financial condition, and cash flows are contingent upon the duration and severity of the outbreak.

Our acquisitions of Angelic and Bantam included provisions for contingent consideration for the earn-outs associated with these transactions. See further discussion in Note 3.

Note 7 – Goodwill and Other Intangible Assets

Goodwill attributable to the Retail and Foodservice segments was $157.4 million and $51.0 million, respectively, at March 31, 2020 and June 30, 2019.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

The following table summarizes our identifiable other intangible assets:

	March 31, <br>2020			June 30, <br>2019
Tradenames (20 to 30-year life)
Gross carrying value	$	63,121		$	63,121
Accumulated amortization	(9,277		)	(7,335		)
Net carrying value	$	53,844		$	55,786
Customer Relationships (10 to 15-year life)
Gross carrying value	$	17,507		$	17,507
Accumulated amortization	(10,731		)	(9,641		)
Net carrying value	$	6,776		$	7,866
Technology / Know-how (10-year life)
Gross carrying value	$	8,950		$	8,950
Accumulated amortization	(3,172		)	(2,501		)
Net carrying value	$	5,778		$	6,449
Non-compete Agreements (5-year life)
Gross carrying value	$	791		$	791
Accumulated amortization	(729		)	(615		)
Net carrying value	$	62		$	176
Total net carrying value	$	66,460		$	70,277

Amortization expense for our other intangible assets, which is reflected in Selling, General and Administrative Expenses, was as follows:

	Three Months Ended <br>March 31,				Nine Months Ended <br>March 31,
	2020		2019		2020		2019
Amortization expense	$	1,269	$	1,273	$	3,817	$	3,325

Total annual amortization expense for each of the next five years is estimated to be as follows:

2021	$	4,976
2022	$	4,902
2023	$	4,343
2024	$	4,343
2025	$	4,083

Note 8 – Income Taxes

Prepaid federal income taxes of $10.7 million and $5.2 million were included in Other Current Assets at March 31, 2020 and June 30, 2019, respectively. Prepaid state and local income taxes of $1.1 million and $0.1 million were included in Other Current Assets at March 31, 2020 and June 30, 2019, respectively.

Note 9 – Business Segment Information

Our financial results are presented as two reportable segments: Retail and Foodservice. Costs that are directly attributable to either Retail or Foodservice are charged directly to the appropriate segment. Costs that are deemed to be indirect, excluding corporate expenses and other unusual significant transactions, are allocated to the two reportable segments using a reasonable methodology that is consistently applied.

Retail - The vast majority of the products we sell in the Retail segment are sold through sales personnel, food brokers and distributors in the United States. We have placement of products in grocery produce departments through our refrigerated salad dressings, vegetable dips and fruit dips. Our flatbread products and sprouted grain bakery products are generally placed in the specialty bakery/deli section of the grocery store. We also have products typically marketed in the shelf-stable section of the grocery store, which include salad dressing, slaw dressing and croutons. Within the frozen food section of the grocery store, we sell yeast rolls, garlic breads and mini stuffed bagels.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Foodservice - The vast majority of the products we sell in the Foodservice segment are sold through sales personnel, food brokers and distributors in the United States. Most of the products we sell in the Foodservice segment are custom-formulated and include salad dressings, sandwich and dipping sauces, frozen breads and yeast rolls. The majority of our Foodservice sales are products sold under private label to restaurants. We also manufacture and sell various branded Foodservice products to distributors. Finally, within this segment, we sell other roll products under a transitional co-packing arrangement resulting from the Omni acquisition.

As many of our products are similar between our two segments, our procurement, manufacturing, warehousing and distribution activities are substantially integrated across our operations in order to maximize efficiency and productivity. Consequently, we do not prepare, and our Chief Operating Decision Maker does not review, separate balance sheets for the reportable segments. As such, our external reporting does not include the presentation of identifiable assets by reportable segment. The composition of our identifiable assets at March 31, 2020 is generally consistent with that of June 30, 2019.

We evaluate our Retail and Foodservice segments based on net sales and operating income which follow:

	Three Months Ended <br>March 31,						Nine Months Ended <br>March 31,
	2020			2019			2020			2019
Net Sales
Retail	$	169,414		$	153,038		$	521,701		$	502,088
Foodservice	151,949			164,844			491,833			482,029
Total	$	321,363		$	317,882		$	1,013,534		$	984,117
Operating Income
Retail	$	29,609		$	24,082		$	104,061		$	102,815
Foodservice	9,185			17,124			56,390			55,390
Restructuring and Impairment Charges	—			—			(886		)	—
Corporate Expenses	(8,804		)	(3,878		)	(23,793		)	(10,602		)
Total	$	29,990		$	37,328		$	135,772		$	147,603

The following table sets forth net sales disaggregated by class of similar products for the Retail and Foodservice segments:

	Three Months Ended <br>March 31,				Nine Months Ended <br>March 31,
	2020		2019		2020		2019
Retail
Frozen breads	$	68,682	$	59,846	$	221,084	$	207,256
Refrigerated dressings, dips and other	49,479		47,900		163,521		164,973
Shelf-stable dressings and croutons	51,253		45,292		137,096		129,859
Total Retail net sales	$	169,414	$	153,038	$	521,701	$	502,088
Foodservice
Dressings and sauces	$	106,306	$	115,746	$	341,039	$	347,583
Frozen breads and other	40,339		41,230		131,300		122,742
Other roll products	5,304		7,868		19,494		11,704
Total Foodservice net sales	$	151,949	$	164,844	$	491,833	$	482,029
Total net sales	$	321,363	$	317,882	$	1,013,534	$	984,117

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

The following table provides an additional disaggregation of Foodservice net sales by type of customer:

	Three Months Ended <br>March 31,				Nine Months Ended <br>March 31,
	2020		2019		2020		2019
Foodservice
National accounts	$	110,384	$	119,875	$	356,192	$	356,102
Branded and other	36,261		37,101		116,147		114,223
Other roll products	5,304		7,868		19,494		11,704
Total Foodservice net sales	$	151,949	$	164,844	$	491,833	$	482,029

Note 10 – Stock-Based Compensation

There have been no changes to our stock-based compensation plans from those disclosed in our 2019 Annual Report on Form 10-K.

Our stock-settled stock appreciation rights (“SSSARs”) compensation expense was $0.7 million for the three months ended March 31, 2020 and 2019. Year-to-date SSSARs compensation expense was $2.2 million for the current-year period compared to $2.3 million for the prior-year period. At March 31, 2020, there was $7.0 million of unrecognized compensation expense related to SSSARs that we will recognize over a weighted-average period of 2 years.

Our restricted stock compensation expense was $0.7 million and $0.5 million for the three months ended March 31, 2020 and 2019, respectively. Year-to-date restricted stock compensation expense was $2.1 million for the current-year period compared to $2.2 million for the prior-year period. At March 31, 2020, there was $6.4 million of unrecognized compensation expense related to restricted stock that we will recognize over a weighted-average period of 2 years.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Our fiscal year begins on July 1 and ends on June 30. Unless otherwise noted, references to “year” pertain to our fiscal year; for example, 2020 refers to fiscal 2020, which is the period from July 1, 2019 to June 30, 2020.

The following discussion should be read in conjunction with our condensed consolidated financial statements and the notes thereto, all included elsewhere in this report, and our 2019 Annual Report on Form 10-K. The forward-looking statements in this section and other parts of this report involve risks, uncertainties and other factors, including statements regarding our plans, objectives, goals, strategies, and financial performance. Our actual results could differ materially from the results anticipated in these forward-looking statements due to these factors. For more information, see the section below entitled “Forward-Looking Statements.”

OVERVIEW

Business Overview

Lancaster Colony Corporation is a manufacturer and marketer of specialty food products for the retail and foodservice channels.

Over 95% of our products are sold in the United States. Foreign operations and export sales have not been significant in the past and are not expected to be significant in the future based upon existing operations. We do not have any fixed assets located outside of the United States.

Our business has the potential to achieve future growth in sales and profitability due to attributes such as:

•	leading Retail market positions in several product categories with a high-quality perception;
•	recognized innovation in Retail products;
---	---
•	a broad customer base in both Retail and Foodservice accounts;
---	---
•	well-regarded culinary expertise among Foodservice customers;
---	---
•	recognized leadership in Foodservice product development;
---	---
•	experience in integrating complementary business acquisitions; and
---	---
•	historically strong cash flow generation that supports growth opportunities.
---	---

Our goal is to grow both Retail and Foodservice segment sales over time by:

•	introducing new products and expanding distribution;
•	leveraging the strength of our Retail brands to increase current product sales;
---	---
•	expanding Retail growth through strategic licensing agreements;
---	---
•	continuing to rely upon the strength of our reputation in Foodservice product development and quality; and
---	---
•	acquiring complementary businesses.
---	---

With respect to long-term growth, we continually evaluate the future opportunities and needs for our business specific to our plant infrastructure, IT platforms and other initiatives to support and strengthen our operations. Recent examples of resulting investments include a significant capacity expansion project for our Sister Schubert’s frozen dinner roll facility in Horse Cave, Kentucky that was completed in January 2020; a new R&D center that was completed near the end of 2019; and the establishment of a Transformation Program Office in 2019 that will serve to coordinate our various capital and integration efforts, including our enterprise resource planning system (“ERP”) that is now underway.

We also continue to review potential acquisitions that we believe will complement our existing product lines, enhance our profitability and/or offer good expansion opportunities in a manner that fits our overall strategic goals. Consistent with this acquisition strategy, on November 16, 2018, we acquired, using available cash on hand, substantially all of the assets of Omni Baking Company LLC (“Omni”), a long-time supplier of products to our frozen garlic bread operations. On October 19, 2018, we acquired, using available cash on hand, all the assets of Bantam Bagels, LLC (“Bantam”), a producer and marketer of frozen mini stuffed bagels and other frozen bread products sold to both the retail and foodservice channels. See further discussion of these acquisitions in Note 2 to the condensed consolidated financial statements.

RECENT EVENTS

A novel strain of coronavirus (“COVID-19”) was first identified in Wuhan, China in December 2019. On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. To date, COVID-19 has surfaced in nearly all regions around the world and resulted in business slowdowns or shutdowns in affected areas. In the U.S., state and local

governments recommended or mandated actions to slow the transmission of COVID-19. These measures include limitations on public gatherings, social distancing requirements, travel restrictions, closures of bars and dine-in restaurants, stay-at-home orders, quarantines and restrictions that prohibit many non-essential employees from going to work.

We have two major priorities while navigating through this period of volatility and uncertainty:

1.	to ensure the health, safety and welfare of our employees; and
2.	to continue to play our part in the vital food supply chain by adequately supplying our customers while maintaining the financial strength of our business.
---	---

With respect to our efforts to ensure the health, safety and welfare of our employees, we are complying with all guidelines issued by the Centers for Disease Control and Prevention as well as state and local health departments. We have also engaged a pulmonology and critical care physician to advise us on our employee safety protocols. Based on the advice of these experts, we have put in place a range of safety modifications and guidelines in our factories, distribution centers and offices to ensure that we can operate safely, including but not limited to:

•	engaging a third party to conduct employee temperature checks prior to entering our production facilities;
•	conducting extensive cleaning and sanitation of workstations and common areas before, during, and after each shift;
---	---
•	employing social distancing guidelines and modifications at workspaces and in break areas;
---	---
•	staggering between shift changes and breaks;
---	---
•	relaxing attendance requirements and enhancing our paid leave policy;
---	---
•	implementing quarantine protocols in the event of confirmed or suspected cases of COVID-19;
---	---
•	providing a $300 bonus for each of our front-line employees in late March and increasing the wage rate for our hourly front-line employees by $2 per hour beginning in April through the end date of the applicable stay-at-home order;
---	---
•	establishing business travel restrictions; and
---	---
•	working from home whenever possible, consistent with the applicable stay-at-home order.
---	---

With respect to our second priority, as of the date of this filing, there has been no material adverse change in our ability to manufacture and distribute our products. We have not experienced any significant disruptions to our shipping or warehousing operations or sourcing of raw materials. We are also pursuing additional second-sourcing options to help limit the risk of supply disruptions.

We continue to monitor the rapidly evolving situation and guidance from authorities, including federal, state and local public health departments, and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our plans. As such, given the dynamic nature of this situation, we cannot reasonably estimate the impact of COVID-19 on our results of operations, financial condition, or cash flows in the future. However, we do expect that it could have a material adverse impact on our future revenue growth as well as our overall profitability and may lead to higher-than-normal inventory levels, revised payment terms with certain of our customers, additional reserves for inventory and receivables, and higher plant operating costs.

During the three months ended March 31, 2020, particularly the month of March, the effects of COVID-19 and the related actions undertaken in the U.S. to attempt to control its spread, specifically the restriction of restaurant dine-in purchases and imposition of stay-at-home orders, negatively impacted the operating results of our Foodservice segment. In the three-month period, our Foodservice segment sales declined 8% to $151.9 million while segment operating income fell 46% to $9.2 million, including a $4.5 million inventory write-down attributed to the abrupt mid-March slowdown in our Foodservice demand. We anticipate Foodservice segment sales will continue to be negatively impacted and the recovery period for this segment’s sales and operating results is contingent upon the timeline for the resumption of full-service operations at U.S. restaurants, the lifting of stay-at-home orders, the overall pace of the U.S. economic recovery and the willingness of consumers to return to away-from-home dining.

With respect to our Retail segment, the impact of COVID-19 resulted in an increase in sales during the three months ended March 31, 2020, particularly starting mid-March, as consumer food purchases transitioned away from the foodservice channel and into the retail channel. We anticipate this sales shift to our Retail segment will continue at least until U.S. restaurants can resume normal operations and consumers return to more typical levels of spending in the foodservice channel.

Our Foodservice segment, which in 2019 accounted for 50% of our total net sales and approximately 65% of our total pounds produced, is undergoing reduced throughput due to the impact of COVID-19, which will result in a reduction in the recovery of our fixed manufacturing and overhead costs, and will therefore unfavorably influence our financial results.

We continue to operate from a position of financial strength and believe that cash provided by operating activities and our existing balances in cash and equivalents, in addition to our access to capital under our unsecured revolving credit facility, should be adequate to meet our liquidity needs over the next 12 months. We are also putting a greater emphasis on tracking the

financial strength of our customers and suppliers and taking actions, where determined necessary, to limit our financial exposure and operational risks. Additional details regarding our financial strength are provided in the “Financial Condition” section below.

RESULTS OF CONSOLIDATED OPERATIONS

(Dollars in thousands,<br><br>except per share data)	Three Months Ended <br>March 31,											Nine Months Ended <br>March 31,
	2020			2019			Change					2020			2019			Change
Net Sales	$	321,363		$	317,882		$	3,481		1	%	$	1,013,534		$	984,117		$	29,417		3	%
Cost of Sales	244,401			242,485			1,916			1	%	744,575			736,129			8,446			1	%
Gross Profit	76,962			75,397			1,565			2	%	268,959			247,988			20,971			8	%
Gross Margin	23.9		%	23.7		%						26.5		%	25.2		%
Selling, General and Administrative Expenses	46,907			37,981			8,926			24	%	132,109			109,902			22,207			20	%
Change in Contingent Consideration	65			88			(23		)	(26	)%	192			(9,517		)	9,709			(102	)%
Restructuring and Impairment Charges	—			—			—			N/M		886			—			886			N/M
Operating Income	29,990			37,328			(7,338		)	(20	)%	135,772			147,603			(11,831		)	(8	)%
Operating Margin	9.3		%	11.7		%						13.4		%	15.0		%
Other, Net	727			1,329			(602		)	(45	)%	3,031			3,682			(651		)	(18	)%
Income Before Income Taxes	30,717			38,657			(7,940		)	(21	)%	138,803			151,285			(12,482		)	(8	)%
Taxes Based on Income	8,288			8,053			235			3	%	32,205			33,746			(1,541		)	(5	)%
Effective Tax Rate	27.0		%	20.8		%						23.2		%	22.3		%
Net Income	$	22,429		$	30,604		$	(8,175	)	(27	)%	$	106,598		$	117,539		$	(10,941	)	(9	)%
Diluted Net Income Per Common Share	$	0.81		$	1.11		$	(0.30	)	(27	)%	$	3.87		$	4.26		$	(0.39	)	(9	)%

Net Sales

Consolidated net sales for the three months ended March 31, 2020 increased 1% to a third quarter record $321.4 million versus $317.9 million last year. This growth was driven by an increase in Retail segment net sales partially offset by a decline in Foodservice segment net sales. Consolidated net sales for the nine months ended March 31, 2020 increased 3% due to higher sales for both segments. See discussion of net sales by segment following the discussion of “Earnings Per Share” below.

Gross Profit

Consolidated gross profit for the three months ended March 31, 2020 increased $1.6 million, or 2%, to $77.0 million compared to the prior-year period. The increase was driven by the favorable sales mix shift to the Retail segment and our cost savings programs. Gross profit was unfavorably impacted by a $4.5 million inventory write-down attributed to an abrupt mid-March slowdown in Foodservice demand due to the impact of COVID-19. In addition, the company incurred a charge of $1.0 million for bonuses paid to the front-line employees in our factories and distribution network in gratitude for their work in helping us meet the shifting demand within our business.

Consolidated gross profit for the nine months ended March 31, 2020 increased $21.0 million, or 8%, to $269.0 million compared to the prior-year period. The increase was driven by the higher sales volumes, our cost savings programs, lower commodity costs and improved net price realization, as partially offset by the impact of COVID-19.

Selling, General and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses increased 24% for the three months ended March 31, 2020 and increased 20% for the year-to-date period. These increases were primarily driven by ERP expenses, higher IT-related costs and increased consumer spending, as well as higher bad debt expense related to the impact of COVID-19. ERP expenses are included within Corporate Expenses.

	Three Months Ended <br>March 31,								Nine Months Ended <br>March 31,
(Dollars in thousands)	2020		2019		Change				2020		2019		Change
SG&A Expenses - Excluding ERP	$	42,030	$	37,981	$	4,049	11	%	$	119,617	$	109,902	$	9,715	9	%
ERP Expenses	4,877		—		4,877		N/M		12,492		—		12,492		N/M
Total SG&A Expenses	$	46,907	$	37,981	$	8,926	24	%	$	132,109	$	109,902	$	22,207	20	%

Change in Contingent Consideration

The change in contingent consideration resulted in expense of $0.1 million and $0.2 million for the three and nine months ended March 31, 2020, respectively, compared to expense of $0.1 million and a net benefit of $9.5 million for the three and nine months ended March 31, 2019, respectively. The prior-year net benefit for the year-to-date period reflected a $9.7 million reduction in the fair value of the contingent consideration liability for Angelic Bakehouse, Inc. (“Angelic”) as a result of our December 31, 2018 fair value measurement. See further discussion in Note 3 to the condensed consolidated financial statements.

Restructuring and Impairment Charges

In the fourth quarter of 2019, we committed to a plan to close our frozen bread manufacturing plant located in Saraland, Alabama. This decision was intended to provide greater production efficiency by consolidating most of this facility’s operations into other existing plants, outsourcing certain requirements and discontinuing less profitable frozen bread products. Production at the plant ceased in July 2019. The operations of this plant have not been classified as discontinued operations as the closure did not represent a strategic shift that would have a major effect on our operations or financial results.

We recorded restructuring and impairment charges of $0.9 million for the nine months ended March 31, 2020, which primarily consisted of plant clean-up expenses and contract termination costs. These charges were not allocated to our two reportable segments due to their unusual nature. All of these charges were recorded in the three months ended September 30, 2019, and we do not expect any additional charges attributed to this plant closure.

Operating Income

Operating income decreased 20% and 8% for the three and nine months ended March 31, 2020, respectively. For the quarter, operating income was unfavorably influenced by the $4.5 million write-down of Foodservice inventory and higher SG&A costs, including ERP expenses. The change in operating income for the year-to-date period was also unfavorably impacted by the prior-year benefit from the reduction in the fair value of Angelic’s contingent consideration and the current-year restructuring and impairment charges. See discussion of operating results by segment following the discussion of “Earnings Per Share” below.

Taxes Based on Income

Our effective tax rate was 23.2% and 22.3% for the nine months ended March 31, 2020 and 2019, respectively. For the nine months ended March 31, 2020 and 2019, our effective tax rate varied from the statutory federal income tax rate as a result of the following factors:

	Nine Months Ended <br>March 31,
	2020		2019
Statutory rate	21.0	%	21.0	%
State and local income taxes	2.9		2.5
Net windfall tax benefits - stock-based compensation	(0.9	)	(1.0	)
Other	0.2		(0.2	)
Effective rate	23.2	%	22.3	%

We include the tax consequences related to stock-based compensation within the computation of income tax expense. We may experience increased volatility to our income tax expense and resulting net income dependent upon, among other variables, the price of our common stock and the timing and volume of share-based payment award activity such as employee exercises of stock-settled stock appreciation rights and vesting of restricted stock awards. For the nine months ended March 31, 2020 and 2019, the impact of net windfall tax benefits from stock-based compensation reduced our effective tax rate by 0.9% and 1.0%, respectively.

Earnings Per Share

As influenced by the factors noted above, diluted net income per share for the third quarter of 2020 totaled $0.81, as compared to $1.11 per diluted share in the prior year. Year-to-date net income per share was $3.87 per diluted share, as compared to $4.26 per diluted share for the prior-year period. Diluted weighted average common shares outstanding have remained relatively stable for the current and prior-year periods ended March 31.

In 2020, spend for the ERP reduced diluted earnings per share by $0.13 and $0.34 for the third quarter and year-to-date periods, respectively. The Foodservice inventory write-down and bonuses paid to front-line employees reduced net income per diluted share by $0.15 for the current-year third quarter and year-to-date periods. The restructuring and impairment charge had an unfavorable impact of $0.02 per diluted share for the nine months ended March 31, 2020. In 2019, the reduction in the fair value of Angelic’s contingent consideration liability increased diluted earnings per share by $0.27 for the year-to-date period.

RESULTS OF OPERATIONS - SEGMENTS

Retail Segment

	Three Months Ended <br>March 31,										Nine Months Ended <br>March 31,
(Dollars in thousands)	2020			2019			Change				2020			2019			Change
Net Sales	$	169,414		$	153,038		$	16,376	11	%	$	521,701		$	502,088		$	19,613	4	%
Operating Income	$	29,609		$	24,082		$	5,527	23	%	$	104,061		$	102,815		$	1,246	1	%
Operating Margin	17.5		%	15.7		%					19.9		%	20.5		%

For the three months ended March 31, 2020, Retail segment net sales increased 11%. Retail net sales benefited from higher demand as the COVID-19 outbreak and related stay-at-home orders led to increased consumption in the retail channel. New products introduced during the quarter also contributed to Retail sales growth. The higher sales volumes were led by frozen garlic bread, shelf-stable dressings and sauces sold under license agreements and frozen dinner rolls.

Year-to-date net sales for the Retail segment reached $521.7 million, a 4% increase from the prior-year total of $502.1 million driven by higher sales of frozen garlic bread, croutons, shelf-stable dressings and sauces sold under license agreements and frozen dinner rolls. The sales increase is due in part to higher retail channel demand attributed to the impact of COVID-19 along with the strategic growth initiatives we have implemented for our Retail segment.

For the three months ended March 31, 2020, Retail segment operating income increased 23%, reflecting benefits from the increased sales volume, our cost savings programs and improved net price realization.

For the nine months ended March 31, 2020, Retail segment operating income increased 1% as the prior-year results were favorably impacted by the $9.7 million reduction in the fair value of Angelic’s contingent consideration liability. Retail segment operating income benefited from the higher sales volumes, our cost savings programs and improved net price realization, as partially offset by higher trade and consumer promotional spending.

Foodservice Segment

	Three Months Ended <br>March 31,											Nine Months Ended <br>March 31,
(Dollars in thousands)	2020			2019			Change					2020			2019			Change
Net Sales	$	151,949		$	164,844		$	(12,895	)	(8	)%	$	491,833		$	482,029		$	9,804	2	%
Operating Income	$	9,185		$	17,124		$	(7,939	)	(46	)%	$	56,390		$	55,390		$	1,000	2	%
Operating Margin	6.0		%	10.4		%						11.5		%	11.5		%

For the three months ended March 31, 2020, Foodservice segment net sales decreased 8%. Excluding all sales attributed to Omni, Foodservice segment net sales declined 7% as foodservice channel demand was unfavorably influenced by the impact of COVID-19. Omni sales totaled $5.3 million in the current year compared to $7.9 million in the prior year. Note that Omni sales are attributed to a temporary supply agreement that is expected to end by December 2020 with declining sales projected through the end of the agreement.

For the nine months ended March 31, 2020, Foodservice segment net sales increased 2%. Excluding all sales attributed to Omni, Foodservice segment net sales were nearly flat as the decline in national chain restaurant sales resulting from the impact of COVID-19 was offset by higher Bantam sales and improved sales for branded products and frozen pasta products. Omni sales totaled $19.5 million in the current year compared to $11.7 million in the prior year.

The decline in Foodservice segment operating income for the three months ended March 31, 2020 reflects the impact of the sales decline and the $4.5 million inventory write-down, both of which are attributed to the impact of COVID-19. The

modest increase in Foodservice segment operating income for the nine months ended March 31, 2020 is attributed to a more favorable sales mix and the benefits from our cost savings programs which were nearly offset by the unfavorable impact of COVID-19.

Corporate Expenses

For the three months ended March 31, 2020 and 2019, corporate expenses totaled $8.8 million and $3.9 million, respectively. For the nine months ended March 31, 2020 and 2019, corporate expenses totaled $23.8 million and $10.6 million, respectively. The increase for both periods was primarily driven by ERP expenses which totaled $4.9 million and $12.5 million for the three and nine months ended March 31, 2020, respectively. For the nine months ended March 31, 2020, we also capitalized an additional $4.9 million of ERP-related expenditures for application development stage activities.

LOOKING FORWARD

Looking forward to our fiscal fourth quarter, our Foodservice segment sales will continue to be unfavorably influenced by the impact of the COVID-19 pandemic as the restaurant industry experiences steep sales declines due to restrictions on dine-in purchases and the imposition of stay-at-home orders. The full impact of these circumstances on our Foodservice segment sales and operating results is difficult to quantify based on the uncertainty surrounding the timeline for the resumption of full-service operations at U.S. restaurants, the lifting of stay-at-home orders, the overall pace of the U.S. economic recovery and the willingness of consumers to return to away-from-home dining. We anticipate that since the Foodservice segment accounted for 50% of our total net sales and approximately 65% of our total pounds produced in 2019, notable declines in our Foodservice segment sales will unfavorably impact the absorption of fixed manufacturing and overhead expenses. We have taken actions to reduce costs resulting from the lower Foodservice segment demand including voluntary furlough programs. We anticipate fiscal fourth quarter Retail segment sales will continue to benefit from the shift in consumer purchases to retail stores due to the stay-at-home orders and other changes in consumer behavior attributed to COVID-19. Note that under the current environment, new product launches into the retail channel are subject to delay by some retailers as they focus their efforts on stocking shelves with existing items and, in some cases, forgo shelf resets to introduce new items. With respect to our ERP initiative, considering the current environment resulting from the impact of COVID-19, we are delaying the implementation timeframe for the project but will continue with our design stage efforts.

FINANCIAL CONDITION

For the nine months ended March 31, 2020, net cash provided by operating activities totaled $119.1 million, as compared to $143.4 million in the prior-year period. This decrease was due to the year-over-year change in net working capital and lower net income, as partially offset by the impact of the prior-year reduction in the fair value of Angelic’s contingent consideration and the current-year increase in the deferred income tax liability due to additional bonus depreciation taken for tax purposes.

Cash used in investing activities for the nine months ended March 31, 2020 was $72.4 million, as compared to $102.1 million in the prior year. This decrease primarily reflects the impact of the prior-year second quarter acquisitions of Bantam and Omni as partially offset by a higher level of capital expenditures paid in the current year. The year-over-year increase in our capital expenditures includes spending on a capacity expansion project at our frozen dinner roll facility in Horse Cave, Kentucky that was completed in January 2020 and the purchase of the Omni manufacturing facility that was previously leased.

Cash used in financing activities for the nine months ended March 31, 2020 of $65.2 million increased from the prior-year total of $59.7 million. This increase was primarily due to higher dividend payments.

Under our unsecured revolving credit facility (“Facility”), we may borrow up to a maximum of $150 million at any one time. We had no borrowings outstanding under the Facility at March 31, 2020. At March 31, 2020, we had $2.8 million of standby letters of credit outstanding, which reduced the amount available for borrowing under the Facility. The Facility expires in March 2025, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternate base rate defined in the Facility. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Due to the nature of its terms, when we have outstanding borrowings under the Facility, they will be classified as long-term debt.

The Facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions, and financial covenants relating to interest coverage and leverage. At March 31, 2020, we were in compliance with all applicable provisions and covenants of this facility, and we exceeded the requirements of the financial covenants by substantial margins. At March 31, 2020, there were no events that would constitute a default under this facility.

We currently expect to remain in compliance with the Facility’s covenants for the foreseeable future. However, a default under the Facility could accelerate the repayment of any then outstanding indebtedness and limit our access to $75 million of additional credit available under the Facility. Such an event could require a reduction in or curtailment of cash dividends or

share repurchases, reduce or delay beneficial expansion or investment plans, or otherwise impact our ability to meet our obligations when due.

We believe that cash provided by operating activities and our existing balances in cash and equivalents, in addition to that available under the Facility, should be adequate to meet our liquidity needs over the next 12 months, including the projected levels of capital expenditures and dividend payments. Due to the recent shifts in demand between our Retail and Foodservice segments and uncertainty attributed to the impact of COVID-19, we have canceled the planned expansion of our dressing and sauce production facility in Horse Cave, Kentucky and terminated the related design/build agreement effective May 1, 2020. We are obligated to pay for work completed as of the date of termination and for any costs actually incurred as a result of the termination, which are not expected to be material. Based on our current plans and expectations, we believe our capital expenditures for 2020 will total approximately $90 million. If we were to borrow outside of the Facility under current market terms, our average interest rate may increase and have an adverse effect on our results of operations.

CONTRACTUAL OBLIGATIONS

We have various contractual obligations that are appropriately recorded as liabilities in our condensed consolidated financial statements. Certain other contractual obligations are not recognized as liabilities in our condensed consolidated financial statements. Examples of such items are commitments to purchase raw materials or packaging inventory that has not yet been received as of March 31, 2020. There have been no significant changes to the contractual obligations disclosed in our 2019 Annual Report on Form 10-K aside from expected changes in raw-material costs associated with changes in product demand or pricing.

CRITICAL ACCOUNTING POLICIES

There have been no changes in critical accounting policies from those policies disclosed in our 2019 Annual Report on Form 10-K. We adopted the new lease accounting guidance on July 1, 2019. See expanded disclosure of lease accounting policies in Note 5 to the condensed consolidated financial statements.

RECENT ACCOUNTING PRONOUNCEMENTS

Recent accounting pronouncements and their impact on our consolidated financial statements are disclosed in Note 1 to the condensed consolidated financial statements.

FORWARD-LOOKING STATEMENTS

We desire to take advantage of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). This Quarterly Report on Form 10-Q contains various “forward-looking statements” within the meaning of the PSLRA and other applicable securities laws. Such statements can be identified by the use of the forward-looking words “anticipate,” “estimate,” “project,” “believe,” “intend,” “plan,” “expect,” “hope” or similar words. These statements discuss future expectations; contain projections regarding future developments, operations or financial conditions; or state other forward-looking information. Such statements are based upon assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements involve various important risks, uncertainties and other factors that could cause our actual results to differ materially from those expressed in the forward-looking statements. Actual results may differ as a result of factors over which we have no, or limited, control including, without limitation, the specific influences outlined below, many of which could be amplified by the COVID-19 pandemic. Management believes these forward-looking statements to be reasonable; however, one should not place undue reliance on such statements that are based on current expectations. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update such forward-looking statements, except as required by law.

Items which could impact these forward-looking statements include, but are not limited to:

•	significant shifts in consumer demand and disruptions to our employees, communities, customers, supply chains, operations, and production processes resulting from COVID-19 and other epidemics, pandemics or similar widespread public health concerns and disease outbreaks;
•	efficiencies in plant operations;
---	---
•	dependence on contract manufacturers, distributors and freight transporters, including their financial strength in continuing to support our business;
---	---
•	fluctuations in the cost and availability of ingredients and packaging;
---	---
•	the potential for loss of larger programs or key customer relationships;
---	---
•	capacity constraints that may affect our ability to meet demand or may increase our costs;
---	---
•	changes in demand for our products, which may result from loss of brand reputation or customer goodwill;
---	---

•	difficulties in designing and implementing our new enterprise resource planning system;
•	cyber-security incidents, information technology disruptions, and data breaches;
---	---
•	ability to successfully grow recently acquired businesses;
---	---
•	the extent to which recent and future business acquisitions are completed and acceptably integrated;
---	---
•	price and product competition;
---	---
•	the lack of market acceptance of new products;
---	---
•	the success and cost of new product development efforts;
---	---
•	the impact of customer store brands on our branded retail volumes;
---	---
•	the reaction of customers or consumers to price increases we may implement;
---	---
•	adverse changes in freight, energy or other costs of producing, distributing or transporting our products;
---	---
•	stability of labor relations;
---	---
•	dependence on key personnel and changes in key personnel;
---	---
•	the effect of consolidation of customers within key market channels;
---	---
•	the impact of fluctuations in our pension plan asset values on funding levels, contributions required and benefit costs;
---	---
•	the possible occurrence of product recalls or other defective or mislabeled product costs;
---	---
•	maintenance of competitive position with respect to other manufacturers;
---	---
•	changes in estimates in critical accounting judgments;
---	---
•	the impact of any regulatory matters affecting our food business, including any required labeling changes and their impact on consumer demand;
---	---
•	the outcome of any litigation or arbitration;
---	---
•	adequate supply of skilled labor; and
---	---
•	certain other factors, including the information disclosed in our discussion of risk factors under Item 1A of our 2019 Annual Report on Form 10-K.
---	---

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our market risks have not changed materially from those disclosed in our 2019 Annual Report on Form 10-K.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this Quarterly Report on Form 10-Q, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2020 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is 1) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and 2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.

(b) Changes in Internal Control Over Financial Reporting. No changes were made to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1A. Risk Factors

Other than the addition of the following item, there have been no material changes to the risk factors disclosed under Item 1A in our 2019 Annual Report on Form 10-K.

Epidemics, pandemics or similar widespread public health concerns and disease outbreaks, such as the novel coronavirus (“COVID-19”), have disrupted and may continue to disrupt consumption, supply chains, operations and production processes, which could have a material adverse effect on our business, results of operations, financial condition and cash flows.

Epidemics, pandemics or similar widespread health concerns and disease outbreaks, such as COVID-19, as well as related government mandates, including the avoidance of gatherings, self-quarantine and the closure of a variety of businesses and restaurants have negatively affected and may continue to negatively affect our business, results of operations, financial condition and cash flows. These effects may include, but are not limited to:

•	significant reductions or volatility in consumer demand for our products as quarantines, stay-at-home orders, travel restrictions, restrictions on gatherings, actual disease outbreaks, customer fears and financial hardship of customers may inhibit consumption or shift demand from discretionary or higher-priced products to lower-priced products and restrict the business operations of our retail and foodservice customers;
•	forced or temporary curtailment of business operations, including the closure of restaurants and restaurant chains or limitations on restaurants to offer only take-out or delivery sales, resulting in a significant reduction in demand for our foodservice products;
---	---
•	failure of third parties on which we rely, including our customers, distributors, suppliers, contract manufacturers, and other partners to meet their obligations to us, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties;
---	---
•	inability to meet our retail customers’ needs and achieve cost targets due to disruption in our manufacturing and supply arrangements caused by the loss or disruption of essential manufacturing and supply elements such as raw materials or other finished product components, transportation, workforce, or other manufacturing and distribution capability; and
---	---
•	disruption in operations if a significant percentage of our workforce is unable to work due to illness, travel or other government restrictions, or other reasons in connection with epidemics, pandemics or disease outbreaks.
---	---

Despite our efforts to manage and remedy these effects, their ultimate significance also depends on factors beyond our knowledge or control, including the duration and severity of any such outbreak as well as third-party actions taken to contain the spread and mitigate public health effects.

In addition, pandemics or disease outbreaks could result in a widespread health crisis that could adversely affect the economies and financial markets of many areas, resulting in economic downturns (local, regional, national, and/or global) that could affect customers’ demand for our products.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) In November 2010, our Board of Directors approved a share repurchase authorization of 2,000,000 common shares, of which 1,316,387 common shares remained authorized for future repurchases at March 31, 2020. This share repurchase authorization does not have a stated expiration date. In the third quarter, we made the following repurchases of our common stock:

Period	Total<br><br>Number of<br><br>Shares<br><br>Purchased	Average<br><br>Price Paid<br><br>Per Share		Total Number<br><br>of Shares<br><br>Purchased as<br><br>Part of<br><br>Publicly<br><br>Announced<br><br>Plans	Maximum<br><br>Number of<br><br>Shares that<br><br>May Yet be<br><br>Purchased<br><br>Under the<br><br>Plans
January 1-31, 2020	—	$	—	—	1,344,099
February 1-29, 2020 ^(1)^	2,660	$	156.95	2,660	1,341,439
March 1-31, 2020 ^(1)^	25,052	$	139.61	25,052	1,316,387
Total	27,712	$	141.27	27,712	1,316,387
(1)	Includes 2,660 shares in February 2020 and 52 shares in March 2020 that were repurchased in satisfaction of tax withholding obligations arising from the vesting of restricted stock granted to employees under the Lancaster Colony Corporation 2015 Omnibus Incentive Plan.
---	---

Item 5. Other Information

On February 27, 2020, T. Marzetti Company (“T. Marzetti”), a wholly-owned subsidiary of ours, entered into a Design/Build Agreement (the “Agreement”) with Gray Construction, Inc. (“Gray”) for the design and construction of an expansion of T. Marzetti’s existing facility in Hart County, Kentucky at a guaranteed maximum price of approximately $80 million. This expansion was intended to support the growth of certain national chain restaurant accounts. Based on the recent shifts in demand between our Retail and Foodservice segments and uncertainty attributed to COVID-19, T. Marzetti terminated the Agreement effective May 1, 2020. T. Marzetti is obligated to pay Gray for work completed as of the date of termination and for any costs actually incurred as a result of the termination, which are not expected to be material.

Item 6. Exhibits

See Index to Exhibits following Signatures.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		LANCASTER COLONY CORPORATION
			(Registrant)
Date:	May 5, 2020	By:	/s/ DAVID A. CIESINSKI
			David A. Ciesinski
			President, Chief Executive Officer
			and Director
			(Principal Executive Officer)
Date:	May 5, 2020	By:	/s/ THOMAS K. PIGOTT
			Thomas K. Pigott
			Chief Financial Officer and Assistant Secretary
			(Principal Financial and Accounting Officer)

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

FORM 10-Q

MARCH 31, 2020

INDEX TO EXHIBITS

Exhibit<br><br>Number	Description
10.1^(a), (b)^	Form of Restricted Stock Award Agreement for Employees and Consultants under the Lancaster Colony Corporation 2015 Omnibus Incentive Plan
10.2^(a), (b)^	Form of Stock Appreciation Rights Agreement for Employees and Consultants under the Lancaster Colony Corporation 2015 Omnibus Incentive Plan
10.3	Design/Build Agreement between T. Marzetti Company and Gray Construction, Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (000-04065), filed February 28, 2020)
10.4	Credit Agreement dated as of March 19, 2020 among Lancaster Colony Corporation, the Lenders, The Huntington National Bank as Syndication Agent and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (000-04065), filed March 20, 2020)
31.1^(b)^	Certification of CEO under Section 302 of the Sarbanes-Oxley Act of 2002
31.2^(b)^	Certification of CFO under Section 302 of the Sarbanes-Oxley Act of 2002
32^(c)^	Certification of CEO and CFO under Section 906 of the Sarbanes-Oxley Act of 2002
101.INS^(b)^	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH^(b)^	Inline XBRL Taxonomy Extension Schema Document
101.CAL^(b)^	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF^(b)^	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB^(b)^	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE^(b)^	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104^(b)^	The cover page of Lancaster Colony Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in Inline XBRL (included within Exhibit 101 attachments)
(a)	Indicates a management contract or compensatory plan, contract or arrangement in which any Director or any Executive Officer participates.
(b)	Filed herewith
(c)	Furnished herewith

		Exhibit

Exhibit 10.1

LANCASTER COLONY CORPORATION

FORM OF RESTRICTED STOCK AWARD AGREEMENT

This Restricted Stock Award Agreement (this “Agreement”) is dated as of __________, 20___, by and between Lancaster Colony Corporation, an Ohio corporation (the “Company”), and __________________, an Employee or Consultant for the Company (the “Grantee”).

W I T N E S S E T H

WHEREAS, the Company desires to award Restricted Stock to the Grantee, subject to the terms and conditions of the Lancaster Colony Corporation 2015 Omnibus Incentive Plan (the “Plan”) and the terms and conditions described below;

WHEREAS, the Grantee wishes to accept such award, subject to the terms and conditions of the Plan and the terms and conditions described below;

WHEREAS, the Company hereby confirms to the Grantee the grant, effective on __________, 20___ (the “Grant Date”), pursuant to the Plan, of _____ shares of Restricted Stock (“Awarded Shares”) subject to the terms and conditions of the Plan and the terms and conditions described below; and

WHEREAS, the parties hereto understand and agree that any terms used and not defined herein have the same meanings as in the Plan.

NOW, THEREFORE, the Company and the Grantee hereby agree as follows:

1.Definitions. As used in this Agreement:

(a)“Compete” means to do any of the following as an officer, director, employee, independent contractor, consultant, owner, partner, member, shareholder, equity holder, or joint venturer of a competitor of the Company, or in any other capacity whatsoever with a competitor of the Company: (a) to directly or indirectly work for a competitor; or (b) to directly or indirectly assist a competitor with one of its existing or prospective goods or services that directly or indirectly competes, will directly or indirectly compete, or would directly or indirectly compete with a good or service directly or indirectly offered, or that may or will be directly or indirectly offered, by the Company.

(b)Confidential Information” means any and all non-public information regarding the Company, its goods, or its services. “Confidential Information” includes any information that qualifies as a “trade secret” under the Uniform Trade Secrets Act or the common law of any state. Additionally, the term “Confidential Information” includes the aforementioned non-public information that has become public because a person or entity breached an obligation to maintain its confidentiality.

(c) “Innovations” shall mean all discoveries, developments, designs, ideas, innovations, improvements, inventions, formulas, processes, techniques, and know-how (whether or not patentable or registrable under copyright, trademark or similar statutes) made, conceived, reduced to practice or learned by the Grantee either alone or jointly with another while in the employ of the Company, or disclosed to a third party by the Grantee within one (1) year of leaving its employ, that

(i)relate directly to the Company’s business or the production of any character of goods or materials sold or used by the Company,

(ii)result from tasks assigned to the Grantee by the Company, or

(iii)result from the use of premises or equipment owned, leased, or otherwise acquired by the Company.

(d)“Protected Territory” includes the following geographic areas: (a) all states and territories of the United States of America; and (b) any other geographic area where it is reasonably necessary for the protection of the

Company’s legitimate interests to restrict Employee from competing and such restriction does not impose an undue hardship on Employee or disregard the interests of the public.

(e)“Third Party” or “Third Parties” means, individually or collectively, any current or prospective client, vendor, or other person or entity in an existing or potential business relationship with the Company during Employee’s employment with the Company or within the two (2) years following Employee’s termination of employment with the Company.“

(f)“Third Party Confidential Information” means any and all non-public information provided to Employee, on a confidential basis, by or on behalf of any existing or potential client, vendor, or other person or entity in an existing or potential business relationship with the Company. Additionally, the term “Third Party Confidential Information” includes the aforementioned non-public information that has become public because a person or entity breached an obligation to maintain its confidentiality.

(g)“Vesting Date” shall mean the earliest of a Change in Control (as such term is defined in the Plan) or the events described in Section 3(b) or Section 3(c).

(h)For purposes of Sections 1(a)-(d) and Sections 1(g)-(h), the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

2.Provisions of the Plan Controlling. The Grantee specifically understands and agrees that the Awarded Shares are being granted under the Plan, and are being granted to the Grantee as Restricted Stock pursuant to the Plan, copies of which the Grantee acknowledges the Grantee has read and understands and by which the Grantee agrees to be bound. The provisions of the Plan are incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and this Agreement, the provisions of the Plan will control.

3.Vesting of Awarded Shares.

(a)Except as provided in Section 3(b), the Awarded Shares shall be forfeited to the Company for no consideration in the event the Grantee ceases to retain Continuous Status as an Employee or Consultant for any reason, voluntarily or involuntarily, prior to the third anniversary of the Grant Date.

(b)The Awarded Shares shall be fully vested in the Grantee and no longer subject to a risk of forfeiture pursuant to Section 3(a) upon the occurrence of the earlier of the following events:

(i)the date on which the Grantee dies or ceases to retain Continuous Status as an Employee or Consultant as a result of the Grantee’s Disability;

(ii)the date upon which the Grantee’s Continuous Status as an Employee or Consultant terminates under circumstances approved by the Administrator, in its sole and absolute discretion, that provide for the full vesting of the Awarded Shares; and

(iii)the third anniversary of the Grant Date.

4.Dividend and Voting Rights.

(a)Dividends payable with respect to the Awarded Shares during the period prior to the Vesting Date shall be paid to the Grantee in the same manner as paid on the Common Stock of the Company, unless the Grantee forfeits the Awarded Shares pursuant to Section 3(a) hereof, in which case the Grantee shall also forfeit the right to receive any dividends not paid prior to such forfeiture.

(b)The Grantee shall have the right to vote any Awarded Shares during the period prior to the Vesting Date; provided, that such voting rights shall lapse with respect to any Awarded Shares that are forfeited to the Company pursuant to this Agreement.

5.Additional Shares. If the Company pays a stock dividend or declares a stock split on or with respect to any of its Common Stock, or otherwise distributes securities of the Company to the holders of its Common Stock, the shares of stock or other securities of the Company issued with respect to the Awarded Shares then subject to the restrictions contained in this Agreement shall be held in escrow and shall be distributed to the Grantee on the Vesting Date, unless the Grantee forfeits the Awarded Shares pursuant to Section 3(a) hereof, in which case the Grantee shall also forfeit the right to receive such stock or other securities. If the Company shall distribute to its shareholders shares of stock of another corporation, the shares of stock of such other corporation distributed with respect to the Awarded Shares then subject to the restrictions contained in this

Agreement shall be held in escrow and shall be distributed to the Grantee on such Vesting Date, unless the Grantee forfeits the Awarded Shares pursuant to Section 2(a) hereof, in which case the Grantee shall also forfeit the right to receive such stock.

6.Effect of Change in Control. Notwithstanding anything in this Agreement to the contrary, including Section 3, in the event of a Change in Control, the Awarded Shares will be affected in accordance with Section 17 of the Plan.

7.Adjustments. The Awarded Shares shall be subject to adjustment in accordance with Section 17 of the Plan.

8.Legends. To the extent certificates representing the Awarded Shares are issued to the Grantee pursuant to this Agreement, such certificates shall have endorsed thereon legends substantially as follows (or in such other form as counsel for the Company may determine is necessary or appropriate):

“The shares represented by this certificate are subject to restrictions set forth in a Restricted Stock Award Agreement with this Company dated __________, 20___, a copy of which Agreement is available for inspection at the offices of the Company or will be made available upon request.”

9.Withholding Taxes. To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with any delivery of Awarded Shares to the Grantee, and the amounts available to the Company for such withholding are insufficient, it shall be a condition to the receipt of such delivery that the Grantee make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld. The Grantee may elect that all or any part of such withholding requirement be satisfied by retention by the Company of a portion of the Awarded Shares to be delivered to the Grantee. If such election is made, the Awarded Shares so retained shall be credited against such withholding requirement at the Fair Market Value (as such term is defined in the Plan) of a Share on the date of such delivery, with any fractional Shares that would otherwise be delivered being rounded up to the next nearest whole Share. In no event shall the Fair Market Value of Awarded Shares to be withheld pursuant to this Section 9 to satisfy applicable withholding taxes in connection with the benefit exceed the minimum amount of taxes required to be withheld.

10.Notices. Any notices required or permitted by the terms of this Agreement or the Plan must be in writing, shall be delivered to the Grantee at his or her address on file with the Company or to the Company addressed as follows (or to such other address or addresses of which notice in the same manner has previously been given), and will be deemed to have been duly given (a) when delivered in person, (b) when dispatched by electronic mail or facsimile transfer, (c) one business day after having been dispatched by a nationally recognized overnight courier service or (d) three business days after being sent by registered or certified mail, return receipt requested, postage prepaid:

Lancaster Colony Corporation

380 Polaris Parkway, Suite 400

Westerville, Ohio 43082

Attention: Corporate Secretary

11.No Employment Contract; Right to Terminate Employment. The grant of the Awarded Shares to the Grantee is a voluntary, discretionary award being made on a one-time basis and it does not constitute a commitment to make any future awards. The grant of the Awarded Shares and any payments made hereunder will not be considered salary or other compensation for purposes of any severance pay or similar allowance, except as otherwise required by law. Nothing in this Agreement will give the Grantee any right to continue employment or to Continuous Status as an Employee or Consultant with the Company or any of its Subsidiaries, as the case may be, or interfere in any way with the right of the Company or any of its subsidiaries to terminate the employment of the Grantee at any time.

12.Relation to Other Benefits. Any economic or other benefit to the Grantee under this Agreement or the Plan shall not be taken into account in determining any benefits to which the Grantee may be entitled under any profit‑sharing, retirement or other benefit or compensation plan maintained by the Company or a subsidiary of the Company and shall not affect the amount of any life insurance coverage available to any beneficiary under any life insurance plan covering employees of the Company or a Subsidiary of the Company.

13.Innovations. In consideration of the Awarded Shares, the Grantee agrees:

(a)For purposes of this Section 13, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies. All Innovations shall belong to and be the exclusive property of the Company.

Company, sign all instruments necessary for the filing and prosecution of any copyrights, patents, mask works, and applications for letters patent of the United States or any foreign country which the Company may desire to file upon such inventions without additional compensation. The Grantee will render all reasonable assistance to the Company and its agents in preparing applications and other documents and do all things that may be reasonable and necessary to protect the rights of the Company and vest in it all such inventions, discoveries, applications, and patents, even if the Grantee is no longer employed by the Company, provided that the Company compensates the Grantee at a reasonable rate for time actually spent by the Grantee on assistance occurring after termination of employment.

(c)That upon termination of employment with the Company for any reason, the Grantee will immediately deliver to the Company all drawings, blueprints, sketches, notebooks, formulae, notes, manuals and other documents reflecting Confidential Information or Innovations, and the Grantee will not retain any copies or versions of such information.

14.Improper Use or Disclosure of Confidential Information. In consideration of the Awarded Shares, the Grantee agrees to the following terms on maintaining confidentiality of certain non-public information:

(a)For purposes of this Section 14, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

(b)The Grantee agrees that during employment with the Company, and at any time thereafter regardless of the reasons for termination, the Grantee will not directly or indirectly do any of the following:

(i)use, or attempt to use, any Confidential Information or Third Party Confidential Information, except as required for the performance of the Grantee’s lawful job duties for the Company;

(ii)disclose, or attempt to disclose, any Confidential Information to any person or entity who, at the time of the disclosure or attempted disclosure, does not have access to the information that was authorized by an agent of the Company with actual authority to provide such access; and/or

(iii)disclose, or attempt to disclose, any Third Party Confidential Information to any person or entity who, at the time of the disclosure or attempted disclosure, does not have access to the information that was authorized by (1) an agent of the Company with actual authority to provide such access and/or (2) an agent of the owner of the Third Party Confidential Information with actual authority to provide such access.

(c)Nothing in Section 14 of this Agreement restricts the Grantee from exercising any rights conferred by Section 7 of the National Labor Relations Act. Additionally, nothing in Section 14 of this Agreement restricts the Grantee from exercising any other rights that are conferred by federal, state, and/or local law and that an agreement such as this is prohibited by law from restricting. Further, nothing in Section 14 of this Agreement restricts the Grantee from reporting conduct the Grantee reasonably, and in good faith, believes to be a violation of federal, state, and/or local law. However, in exercising such rights or in making such reports, the Grantee must act in good faith and not unreasonably or unnecessarily disclose any Confidential Information or Third Party Confidential Information. Furthermore, if any Confidential Information is to be disclosed outside of the Company in exercising such rights or in making such reports, then the Grantee is required to provide prior written notice of the disclosure to Company management, so long as such prior written notice is not prohibited by law. If any Third Party Confidential Information is to be disclosed outside of the Company in exercising such rights or in making such reports, then the Grantee is required to provide prior written notice of the disclosure to Company management and to the management of any affected owner of Third Party Confidential Information, so long as such prior written notice is not prohibited by law. The Grantee must provide the prior written notice on or before the moment the Grantee makes the disclosure.

15.Unfair Competition. In consideration of the Awarded Shares, the Grantee agrees to be prohibited from engaging in unfair competition with the Company both during and after employment as follows:

(a)For purposes of this Section 15, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

acknowledges and agrees that the Company has legitimate interests in restricting the Grantee’s competitive activities both during and after employment with the Company and that the restrictions contained in this Section 15 are necessary to protect those legitimate business interests, are designed to eliminate competition that would be unfair to the Company, are reasonable in time and scope, and do not confer a benefit upon the Company which is disproportionate to any detriment to the Grantee.

(c)The Grantee agrees that during employment with the Company, and for a period of one (1) year thereafter regardless of the reasons for termination, the Grantee will not Compete with the Company, or prepare to Compete with the Company, within the Protected Territory. This restriction applies regardless of whether the Grantee is physically present in the Protected Territory engaging in prohibited competition or whether the Grantee uses means of communication, such as the telephone or the Internet, to engage in prohibited competition within the Protected Territory while physically outside of the Protected Territory. Notwithstanding the foregoing, nothing in this Agreement shall prohibit the Grantee from purchasing or owning less than five percent (5%) of the publicly traded securities of any competitor of the Company’s, provided that such ownership represents a passive investment and that the Grantee is not a controlling person of, or a member of a group that controls, such competitor.

(d)The Grantee agrees that during employment with the Company and for a period of two (2) years thereafter regardless of the reasons for termination, the Grantee will not, to any tangible or intangible detriment of the Company, directly or indirectly do any of the following:

(i)solicit in any way, or attempt to solicit in any way, any business from a Third Party;

(ii)accept any business from, or attempt to accept any business from, a Third Party; and/or

(iii)induce in any way, or attempt to induce in any way, a Third Party to terminate or diminish in any way its existing or prospective business relationship with the Company.

(e)The Grantee agrees that during employment with the Company and for a period of two (2) years thereafter regardless of the reasons for termination, the Grantee will not directly or indirectly do any of the following:

(i)solicit in any way, or attempt to solicit in any way, any current or prospective employee of the Company to decline any prospective employment with the Company or to terminate his or her current employment with the Company; and/or

(ii)induce in any way, or attempt to induce in any way, any current or prospective employee of the Company to decline any prospective employment with the Company or to terminate his or her current employment with the Company.

16.Miscellaneous and Remedies. In consideration of the Awarded Shares, the Grantee agrees to be bound by the following:

(a)For purposes of this Section 16, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

(b)The Grantee represents that the Grantee currently has no restrictions on competition imposed by any agreement with any prior employer, including without limitation any non-competition restriction or non-solicitation restriction, that would prevent the Grantee from working for the Company and performing all lawful duties that the Company may require of the Grantee. By signing this Agreement, the Grantee certifies that the Grantee has made every good faith effort to determine whether any such restrictions exist. The Grantee agrees that the Grantee is prohibited from using or disclosing any confidential business information or trade secrets of a prior employer. This prohibits without limitation any disclosure of such information or trade secrets to any employee of the Company or any use of such information or trade secrets as part of the Grantee’s job duties with the Company. The Grantee further acknowledges that the Company will never directly or indirectly request Employee to improperly use or disclose any prior employer’s confidential information or trade secrets. If any Company employee does make such a request, the Grantee shall immediately report the request to the Company’s Human Resources Department.

(c)The Grantee agrees to notify any of the Grantee’s actual or prospective employers of the existence and terms of this Agreement and agrees that the Company may notify such employers of the terms of this Agreement as well.

be adequately remedied by money damages and will entitle the Company to immediate injunctive relief and/or specific performance in any court of competent jurisdiction, as well as to all other legal or equitable remedies and Uniform Trade Secrets Act remedies, where applicable, to which the Company may be entitled.

(e)If a jury or court of competent jurisdiction finds that the Grantee has breached Section 14 of this Agreement, and this finding becomes final after any appeals are exhausted, then the Grantee is liable to the Company, for each breach, in an amount equal to ten percent (10%) of the Grantee’s last total annual compensation provided by the Company. The Grantee agrees that if the Grantee breaches Section 14 of this Agreement then Company will suffer actual damages in an amount that would be difficult if not impossible to determine and that the liquidated damages imposed for a breach of Section 14 of this Agreement represent the damages fairly estimated by the parties to result from any breach and do not constitute a penalty. Furthermore, the Grantee agrees that the imposition of these liquidated damages does not demonstrate or imply that the Company would not suffer irreparable harm from any breach of this Agreement and does not render improper the award of injunctive relief.

(f)The Grantee agrees that if the Grantee breaches, threatens to breach, or attempts to breach any of the provisions of Section 15(c) following termination of employment with the Company, then the post-employment restricted period for Section 15(c) shall be extended to encompass the period of one (1) year from the date the Company obtains a court order providing preliminary or permanent injunctive relief enjoining the Grantee from any or all acts and/or omissions contrary to Section 15(c). Similarly, if the Grantee breaches, threatens to breach, or attempts to breach any of the provisions of Sections 15(d) and/or 15(e) following termination of employment with the Company, then the restricted period for Sections 15(d) and/or 15(e) shall be extended to encompass the period of two (2) years from the date the Company obtains a court order providing preliminary or permanent injunctive relief enjoining the Grantee from any acts and/or omissions contrary to Sections 15(d) and/or 15(e).

(g)If the Company is, in its sole judgment, compelled to assert a cause of action against the Grantee to enforce or remedy any breach, threatened breach, or attempted breach of Sections 13, 14, and/or 15 of this Agreement, then the Grantee agrees to reimburse the Company for its reasonable attorneys’ fees and other reasonable expenses incurred in the investigation and successful prosecution or settlement of any such cause of action in addition to any damages or other remedies obtained by the Company.

(h)If any part of the restrictions contained in Section 15 of this Agreement are found unenforceable by any court of competent jurisdiction, then the parties agree that they intend for the court to enforce the restrictions to the extent reasonable or enforceable and to not decline enforcement. The parties agree that, in any litigation over Section 15 of this Agreement, they will jointly advocate this position to the court and/or any jury.

17.Information. Information about the Grantee and the Grantee’s participation in the Plan may be collected, recorded and held, used and disclosed for any purpose related to the administration of the Plan. The Grantee understands that such processing of this information may need to be carried out by the Company and its Subsidiaries and by third party administrators whether such persons are located within the Grantee’s country or elsewhere, including the United States of America. The Grantee consents to the processing of information relating to the Grantee and the Grantee’s participation in the Plan in any one or more of the ways referred to above.

18.Benefit of Agreement. Subject to the provisions of the Plan and the other provisions hereof, this Agreement is for the benefit of and is binding on the heirs, executors, administrators, successors and assigns of the parties hereto.

19.Entire Agreement. This Agreement, together with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict the express terms and provisions of this Agreement; provided, however, in any event, this Agreement shall be subject to and governed by the Plan. The Administrator shall have authority, subject to the express provisions of the Plan and this Agreement, to establish, amend and rescind rules and regulations relating to the Plan, and to make all other determinations that are, in the judgment of the Administrator, necessary or desirable for the administration of the Plan. The Administrator may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in this Agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All actions by the Administrator under the provisions of this Section 19 shall be conclusive for all purposes. The Grantee specifically understands and agrees that the Awarded Shares are being granted under the Plan, copies of which Plan the Grantee acknowledges the Grantee has read, understands and by which the Grantee agrees to be bound.

20.Amendments. Any amendment to the Plan shall be deemed to be an amendment to this Agreement to the extent that the amendment is applicable hereto; provided, however, that no amendment shall adversely affect the rights of the Grantee with respect to the Awarded Shares without the Grantee’s consent.

21.Severability. It is the intention and agreement of the Company and the Grantee that this Agreement shall be construed in such a manner as to impose only those restrictions on the conduct of the Grantee that are reasonable in light of the circumstances as they then exist and as are necessary to assure the Company of the intended benefit of this Agreement. In the event that one or more of the provisions of this Agreement shall be invalidated for any reason by a court of competent jurisdiction, any provision so invalidated shall be deemed to be separable from the other provisions hereof, and the remaining provisions hereof shall continue to be valid and fully enforceable.

22.Governing Law. This Agreement is made under, and shall be construed in accordance with the internal substantive laws of the State of Ohio.

23.Waivers and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.

24.Electronic Delivery and Consent to Electronic Participation. The Company may, in its sole discretion, decide to deliver any documents related to the Awarded Shares and participation in the Plan or future grants of Restricted Stock that may be granted under the Plan by electronic means. Notwithstanding anything in this Agreement to the contrary, Grantee hereby consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company, including the acceptance of Restricted Stock grants and the execution of award agreements through electronic signature.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

Executed in the name and on behalf of the Company in Westerville, Ohio as of __________, 20___.

LANCASTER COLONY CORPORATION
By:
	Name: Matthew R. Shurte
	Title: General Counsel

ACCEPTANCE OF AGREEMENT

Grantee hereby: (a) acknowledges receiving a copy of the Plan, which has either been previously delivered or is provided with this Agreement, and represents that he or she is familiar with and understands all provisions of the Plan and this Agreement; (b) voluntarily and knowingly accepts this Agreement and the Awarded Shares granted to him or her under this Agreement subject to all provisions of the Plan and this Agreement; and (c) represents that he or she understands that the acceptance of this Agreement through an on-line or electronic system, if applicable, carries the same legal significance as if he or she manually signed the Agreement. Grantee further acknowledges receiving a copy of the Company’s most recent annual report to shareholders and other communications routinely distributed to the Company’s shareholders and a copy of the prospectus pertaining to the Plan.

Grantee Name:

		Exhibit

Exhibit 10.2

LANCASTER COLONY CORPORATION

FORM OF STOCK APPRECIATION RIGHTS AGREEMENT

This Stock Appreciation Rights Agreement (this “Agreement”) is dated as of __________, 20___, by and between Lancaster Colony Corporation, an Ohio corporation (the “Company”), and __________________, an Employee or Consultant for the Company (the “Grantee”).

W I T N E S S E T H

WHEREAS, the Company desires to award Stock Appreciation Rights to the Grantee, subject to the terms and conditions of the Lancaster Colony Corporation 2015 Omnibus Incentive Plan (the “Plan”) and the terms and conditions described below;

WHEREAS, the Grantee wishes to accept such award, subject to the terms and conditions of the Plan and the terms and conditions described below;

WHEREAS, the Company hereby confirms to the Grantee the grant, effective on __________, 20___ (the “Grant Date”), pursuant to the Plan, of _____ Stock Appreciation Rights (“SARs”) subject to the terms and conditions of the Plan and the terms and conditions described below, which SARs are a right to receive Shares with a Fair Market Value (as such term is defined in the Plan) equal to 100% of the Spread at the time of exercise; and

WHEREAS, the parties hereto understand and agree that any terms used and not defined herein have the same meanings as in the Plan.

NOW, THEREFORE, the Company and the Grantee hereby agree as follows:

1.	Definitions. As used in this Agreement:

(a)“Base Price” means $_______, which is not less than the Fair Market Value of a Share on the Grant Date.

(b)“Compete” means for the Grantee to do any of the following as an officer, director, employee, independent contractor, consultant, owner, partner, member, shareholder, equity holder, or joint venture of a competitor of the Company, or in any other capacity whatsoever with a competitor of the Company: (a) to directly or indirectly work for a competitor; or (b) to directly or indirectly assist a competitor with one of its existing or prospective goods or services that directly or indirectly competes, will directly or indirectly compete, or would directly or indirectly compete with a good or service directly or indirectly offered, or that may or will be directly or indirectly offered, by the Company.

(c) “Confidential Information” means any and all non-public information regarding the Company, its goods, or its services. “Confidential Information” includes any information that qualifies as a “trade secret” under the Uniform Trade Secrets Act or the common law of any state. Additionally, the term “Confidential Information” includes the aforementioned non-public information that has become public because a person or entity breached an obligation to maintain its confidentiality

(d)“Innovations” shall mean all discoveries, developments, designs, ideas, innovations, improvements, inventions, formulas, processes, techniques, and know-how (whether or not patentable or registrable under copyright, trademark or similar statutes) made, conceived, reduced to practice or learned by the Grantee either alone or jointly with another while in the employ of the Company, or disclosed to a third party by the Grantee within one (1) year of leaving its employ, that

(i)relate directly to the Company’s business or the production of any character of goods or materials sold or used by the Company,

(ii)result from tasks assigned to the Grantee by the Company, or

(iii)result from the use of premises or equipment owned, leased, or otherwise acquired by the Company.

(e)“Protected Territory” includes the following geographic areas: (a) all states and territories of the United States of America; and (b) any other geographic area where it is reasonably necessary for the protection of the Company’s legitimate interests to restrict the Grantee from competing and such restriction does not impose an undue hardship on the Grantee or disregard the interests of the public.

(f) “Spread” means the excess of the Fair Market Value of a Share on the date on which a SAR is exercised over the Base Price.

(g)“Third Party” or “Third Parties” mean, individually or collectively, any current or prospective client, vendor, or other person or entity in an existing or potential business relationship with the Company during the Grantee’s employment with the Company or within the two (2) years following the Grantee’s termination of employment with the Company.

(h)“Third Party Confidential Information” means any and all non-public information provided to the Grantee, on a confidential basis, by or on behalf of any existing or potential client, vendor, or other person or entity in an existing or potential business relationship with the Company. Additionally, the term “Third Party Confidential Information” includes the aforementioned non-public information that has become public because a person or entity breached an obligation to maintain its confidentiality.

(i)For purposes of Sections 1(b)-(e) and Sections 1(g)-(h), the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

2.Vesting of SARs. The SARs shall become exercisable as follows:

(a)one-third of the SARs shall become exercisable on the first anniversary of the Grant Date if the Grantee shall have retained Continuous Status as an Employee or Consultant through such date;

(b)an additional one-third of the SARs shall become exercisable on the second anniversary of the Grant Date if the Grantee shall have retained Continuous Status as an Employee or Consultant through such date;

(c)the remaining one-third of the SARs shall become exercisable on the third anniversary of the Grant Date if the Grantee shall have retained Continuous Status as an Employee or Consultant through such date;

provided, that notwithstanding anything in this Section 2 to the contrary, any unexercisable SARs shall become immediately exercisable on: (A) the date upon which the Grantee’s Continuous Status as an Employee or Consultant terminates under circumstances approved by the Administrator, in its sole and absolute discretion, that provide for the vesting of the otherwise unexercisable SARs; or (B) the date on which Grantee dies or ceases to retain Continuous Status as an Employee or Consultant as a result of Grantee’s Disability.

In calculating the one-third amounts described in Sections 2(a) and (b), fractional SARs shall be rounded down to the nearest whole SAR for each of the first two anniversaries of the Grant Date, and the remaining SARs shall be included with those SARs that become exercisable on the third anniversary of the Grant Date. To the extent exercisable, the SARs may be exercised from time to time in accordance with the Plan and this Agreement. To the extent the SARs or any portion thereof do not become exercisable as provided in this Section 2, such unexercisable SARs or portion thereof shall be forfeited to the Company for no consideration.

3.	Exercise of SARs.

(a)To the extent exercisable as provided in Section 2 or Section 5 of this Agreement, the SARs may be exercised in whole or in part by delivery to the Company of a statement in form and substance satisfactory to the Committee specifying the number of SARs to be exercised.

(b)Upon exercise, the Company will issue to the Grantee the number of Shares equal to the quotient of (i) the product of (A) the Spread multiplied by (B) the number of SARs exercised divided by (ii) the Fair Market Value of a Share on the date of exercise, with such quotient rounded down to the nearest whole Share.

4.Termination of SARs. The SARs shall terminate upon the earliest to occur of the following:

(a)90 days after the Grantee ceases to retain Continuous Status as an Employee or Consultant other than upon the Grantee’s death or Disability;

(b)180 days after the Grantee ceases to retain Continuous Status as an Employee or Consultant as a result of the Grantee’s Disability;

(c)One year after the Grantee ceases to retain Continuous Status as an Employee or Consultant as a result of the Grantee’s death; and

(d)Seven years from the Grant Date.

5.Effect of Change in Control. Notwithstanding anything in this Agreement to the contrary, including Section 2, in the event of a Change in Control (as such term is defined in the Plan), the SARs will be affected in accordance with Section 17 of the Plan.

6.Transferability. No SAR may be transferred by the Grantee other than by will or the laws of descent and distribution. The SARs may be exercised during a Grantee’s lifetime only by the Grantee or, in the event of the Grantee legal incapacity, by the Grantee’s guardian or legal representative acting in a fiduciary capacity on behalf of the Grantee under state law and court supervision. The SARs may be exercised after the Grantee’s death by (a) the Grantee’s designated beneficiary, provided such beneficiary has been designated prior to the Grantee’s death in a form acceptable to the Committee, or (b) the personal representative of the Grantee’s estate or by the person(s) to whom the SARs are transferred pursuant to the Grantee’s will or in accordance with the laws of descent and distribution.

7.Compliance with Law. The SARs shall not be exercisable if such exercise would involve a violation of any applicable federal or state securities law, and the Company hereby agrees to make reasonable efforts to comply with any applicable federal and state securities law.

8.Adjustments. The SARs shall be subject to adjustment in accordance with Section 17 of the Plan.

9.Withholding Taxes. To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with the exercise of the SARs, and the amounts available to the Company for such withholding are insufficient, it shall be a condition to such exercise that the Grantee make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld. The Grantee may elect that all or any part of such withholding requirement be satisfied by retention by the Company of a portion of the Shares to be delivered to the Grantee. If such election is made, the Shares so retained shall be credited against such withholding requirement at the Fair Market Value of a Share on the date of such delivery, with any fractional Shares that would otherwise be delivered being rounded up to the next nearest whole Share. In no event shall the Fair Market Value of Shares to be withheld pursuant to this Section 9 to satisfy applicable withholding taxes in connection with the benefit exceed the minimum amount of taxes required to be withheld.

Lancaster Colony Corporation

380 Polaris Parkway, Suite 400

Westerville, Ohio 43082

Attention: Corporate Secretary

11.No Employment Contract; Right to Terminate Employment. The grant of SARs to the Grantee is a voluntary, discretionary award being made on a one-time basis and it does not constitute a commitment to make any future

awards. The grant of the SARs and any payments made hereunder will not be considered salary or other compensation for purposes of any severance pay or similar allowance, except as otherwise required by law. Nothing in this Agreement will give the Grantee any right to continue employment or to Continuous Status as an Employee or Consultant with the Company or any of its Subsidiaries, as the case may be, or interfere in any way with the right of the Company or any of its Subsidiaries to terminate the employment of the Grantee at any time.

12.Relation to Other Benefits. Any economic or other benefit to the Grantee under this Agreement or the Plan shall not be taken into account in determining any benefits to which the Grantee may be entitled under any profit‑sharing, retirement or other benefit or compensation plan maintained by the Company or a Subsidiary and shall not affect the amount of any life insurance coverage available to any beneficiary under any life insurance plan covering employees of the Company or a Subsidiary.

13.Innovations. In consideration of the awarded SARs, the Grantee agrees:

(b)The Grantee will promptly disclose all Innovations to the Company and will assign all of the Grantee’s right, title and interest to such Innovations, whether in the United States and any foreign country, to the Company and its successors and assigns. The Grantee will from time to time, upon request and at the expense of the Company, sign all instruments necessary for the filing and prosecution of any copyrights, patents, mask works, and applications for letters patent of the United States or any foreign country which the Company may desire to file upon such inventions without additional compensation. The Grantee will render all reasonable assistance to the Company and its agents in preparing applications and other documents and do all things that may be reasonable and necessary to protect the rights of the Company and vest in it all such inventions, discoveries, applications, and patents, even if the Grantee is no longer employed by the Company, provided that the Company compensates the Grantee at a reasonable rate for time actually spent by the Grantee on assistance occurring after termination of employment.

14.Improper Use or Disclosure of Confidential Information. In consideration of the awarded SARs, the Grantee agrees to the following terms on maintaining confidentiality of certain non-public information:

(a)For purposes of this Section 14, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

(i)use, or attempt to use, any Confidential Information or Third Party Confidential Information, except as required for the performance of the Grantee’s lawful job duties for the Company;

Grantee from reporting conduct the Grantee reasonably, and in good faith, believes to be a violation of federal, state, and/or local law. However, in exercising such rights or in making such reports, the Grantee must act in good faith and not unreasonably or unnecessarily disclose any Confidential Information or Third Party Confidential Information. Furthermore, if any Confidential Information is to be disclosed outside of the Company in exercising such rights or in making such reports, then the Grantee is required to provide prior written notice of the disclosure to Company management, so long as such prior written notice is not prohibited by law. If any Third Party Confidential Information is to be disclosed outside of the Company in exercising such rights or in making such reports, then the Grantee is required to provide prior written notice of the disclosure to Company management and to the management of any affected owner of Third Party Confidential Information, so long as such prior written notice is not prohibited by law. The Grantee must provide the prior written notice on or before the moment the Grantee makes the disclosure.

15.Unfair Competition. In consideration of the awarded SARs, the Grantee agrees to be prohibited from engaging in unfair competition with the Company both during and after employment as follows:

(a)For purposes of this Section 15, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

(b)The Grantee acknowledges that, by working for the Company, he or she will: (i) have access to, learn about, and work with the Company’s valuable and unique Confidential Information, all of which the Company developed through substantial, time, effort, and expense; (ii) be in contact and develop relationships with Third Parties, the contacts and relationships with whom the Company developed through substantial time, effort, and expense; and (iii) receive valuable training, knowledge, and expertise, some or all of which the Grantee gained in whole or in part through substantial time, effort, and expense by the Company. For these reasons, the Grantee acknowledges and agrees that the Company has legitimate interests in restricting the Grantee’s competitive activities both during and after employment with the Company and that the restrictions contained in this Section 15 are necessary to protect those legitimate business interests, are designed to eliminate competition that would be unfair to the Company, are reasonable in time and scope, and do not confer a benefit upon the Company which is disproportionate to any detriment to the Grantee.

(c)The Grantee agrees that during employment with the Company, and for a period of one (1) year thereafter regardless of the reasons for termination, the Grantee will not Compete with the Company, or prepare to Compete with the Company, within the Protected Territory. This restriction applies regardless of whether the Grantee is physically present in the Protected Territory engaging in prohibited competition or whether the Grantee uses means of communication, such as the telephone or the Internet, to engage in prohibited competition within the Protected Territory while physically outside of the Protected Territory. Notwithstanding the foregoing, nothing in this Agreement shall prohibit the Grantee from purchasing or owning less than five percent (5%) of the publicly traded securities of any competitor of the Company, provided that such ownership represents a passive investment and that the Grantee is not a controlling person of, or a member of a group that controls, such competitor.

(i)solicit in any way, or attempt to solicit in any way, any business from a Third Party;

(ii)accept any business from, or attempt to accept any business from, a Third Party; and/or

(iii)induce in any way, or attempt to induce in any way, a Third Party to terminate or diminish in any way its existing or prospective business relationship with the Company.

16.Miscellaneous and Remedies. In consideration of the awarded SARs, the Grantee agrees to be bound by the following:

(a)For purposes of this Section 16, the “Company” shall mean Lancaster Colony Corporation or any of its parent, subsidiary, or affiliated companies.

(d)The Grantee agrees that any breach, threatened breach, or attempted breach by the Grantee of Sections 13, 14, and/or 15 of this Agreement will cause immediate and irreparable harm to the Company that cannot be adequately remedied by money damages and will entitle the Company to immediate injunctive relief and/or specific performance in any court of competent jurisdiction, as well as to all other legal or equitable remedies and Uniform Trade Secrets Act remedies, where applicable, to which the Company may be entitled.

(e)If a jury or court of competent jurisdiction finds that the Grantee has breached Section 14 of this Agreement, and this finding becomes final after any appeals are exhausted, then the Grantee is liable to the Company, for each breach, in an amount equal to ten percent (10%) of the Grantee’s last total annual compensation provided by the Company. The Grantee agrees that if the Grantee breaches Section 14 of this Agreement, then Company will suffer actual damages in an amount that would be difficult if not impossible to determine and that the liquidated damages imposed for a breach of Section 14 of this Agreement represent the damages fairly estimated by the parties to result from any breach and do not constitute a penalty. Furthermore, the Grantee agrees that the imposition of these liquidated damages does not demonstrate or imply that the Company would not suffer irreparable harm from any breach of this Agreement and does not render improper the award of injunctive relief.

19.Entire Agreement. This Agreement, together with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict the express terms and provisions of this Agreement; provided, however, in any event, this Agreement shall be subject to and governed by the Plan. The Administrator shall have authority, subject to the express provisions of the Plan and this Agreement, to establish, amend and rescind rules and regulations relating to the Plan, and to make all other determinations that are, in the judgment of the Administrator, necessary or desirable for the administration of the Plan. The Administrator may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in this Agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All actions by the Administrator under the provisions of this Section 19 shall be conclusive for all purposes. The Grantee specifically understands and agrees that the SARs are being granted under the Plan, copies of which Plan the Grantee acknowledges the Grantee has read, understands and by which the Grantee agrees to be bound.

22.Governing Law. This Agreement is made under, and shall be construed in accordance with the internal substantive laws of the State of Ohio.

24.Electronic Delivery and Consent to Electronic Participation. The Company may, in its sole discretion, decide to deliver any documents related to the SARs and participation in the Plan or future grants of Stock Appreciation Rights that may be granted under the Plan by electronic means. Notwithstanding anything in this Agreement to the contrary, Grantee hereby consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company, including the acceptance of Stock Appreciation Rights grants and the execution of award agreements through electronic signature.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

Executed in the name and on behalf of the Company in Westerville, Ohio as of __________, 20___.

LANCASTER COLONY CORPORATION
By:
	Name: Matthew R. Shurte
	Title: General Counsel

ACCEPTANCE OF AGREEMENT

Grantee hereby: (a) acknowledges receiving a copy of the Plan, which has either been previously delivered or is provided with this Agreement, and represents that he or she is familiar with and understands all provisions of the Plan and this Agreement; (b) voluntarily and knowingly accepts this Agreement and the SARs granted to him or her under this Agreement subject to all provisions of the Plan and this Agreement; and (c) represents that he or she understands that the acceptance of this Agreement through an on-line or electronic system, if applicable, carries the same legal significance as if he or she manually signed the Agreement. Grantee further acknowledges receiving a copy of the Company’s most recent annual report to shareholders and other communications routinely distributed to the Company’s shareholders and a copy of the prospectus pertaining to the Plan.

Grantee Name:

		Exhibit

Exhibit 31.1

Certification by Chief Executive Officer

I, David A. Ciesinski, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Lancaster Colony Corporation;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
---	---
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
---	---
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
---	---
(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
---	---
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
---	---
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
---	---
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
---	---
5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
---	---
(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
---	---
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
---	---
Date:	May 5, 2020	By:	/s/ DAVID A. CIESINSKI
---	---	---	---
			David A. Ciesinski
			Chief Executive Officer

		Exhibit

Exhibit 31.2

Certification by Chief Financial Officer

I, Thomas K. Pigott, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Lancaster Colony Corporation;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
---	---
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
---	---
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
---	---
(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
---	---
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
---	---
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
---	---
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
---	---
5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
---	---
(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
---	---
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
---	---
Date:	May 5, 2020	By:	/s/ THOMAS K. PIGOTT
---	---	---	---
			Thomas K. Pigott
			Chief Financial Officer

		Exhibit

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18, UNITED STATES CODE, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Lancaster Colony Corporation (the “Company”) on Form 10-Q for the quarter ending March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), David A. Ciesinski, Chief Executive Officer of the Company, and Thomas K. Pigott, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
---	---
By:	/s/ DAVID A. CIESINSKI
---	---
	David A. Ciesinski
	Chief Executive Officer
May 5, 2020
By:	/s/ THOMAS K. PIGOTT
	Thomas K. Pigott
	Chief Financial Officer
May 5, 2020

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

For the transition period from to

Commission file number 000-04065

27,516,000

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (continued)

See accompanying notes to condensed consolidated financial statements.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Summary of Significant Accounting Policies

Basis of Presentation

Deferred Software Costs

Property, Plant and Equipment

Earnings Per Share

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Accumulated Other Comprehensive Loss

Significant Accounting Policies

Recently Issued Accounting Standards

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Recently Adopted Accounting Standards

Note 2 – Acquisitions

Omni Baking Company LLC

Bantam Bagels, LLC

Note 3 – Fair Value

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Bantam Contingent Consideration

Angelic Contingent Consideration

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 4 – Long-Term Debt

Note 5 – Leases

General Lease Description

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Significant Assumptions and Judgments

Contract Contains a Lease

Allocation of Consideration

Options to Extend or Terminate Leases

Discount Rate

3.0%

4.1%

Practical Expedients and Accounting Policy Elections

Amounts Recognized in the Financial Statements

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 6 – Contingencies

Note 7 – Goodwill and Other Intangible Assets

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 8 – Income Taxes

Note 9 – Business Segment Information

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS